<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1 20151215//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing1.dtd?><?SourceDTD.Version 1.1?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Antioxidants (Basel)</journal-id><journal-id journal-id-type="iso-abbrev">Antioxidants (Basel)</journal-id><journal-id journal-id-type="publisher-id">antioxidants</journal-id><journal-title-group><journal-title>Antioxidants</journal-title></journal-title-group><issn pub-type="epub">2076-3921</issn><publisher><publisher-name>MDPI</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">7600529</article-id><article-id pub-id-type="pmid">32993114</article-id><article-id pub-id-type="doi">10.3390/antiox9100919</article-id><article-id pub-id-type="publisher-id">antioxidants-09-00919</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Memory-Enhancing Effects of <italic>Origanum majorana</italic> Essential Oil in an Alzheimer&#x02019;s Amyloid beta1-42 Rat Model: A Molecular and Behavioral Study</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Postu</surname><given-names>Paula Alexandra</given-names></name><xref ref-type="aff" rid="af1-antioxidants-09-00919">1</xref><xref ref-type="aff" rid="af2-antioxidants-09-00919">2</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0001-6454-9092</contrib-id><name><surname>Gorgan</surname><given-names>Dragos Lucian</given-names></name><xref ref-type="aff" rid="af1-antioxidants-09-00919">1</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0001-9173-4832</contrib-id><name><surname>Cioanca</surname><given-names>Oana</given-names></name><xref ref-type="aff" rid="af3-antioxidants-09-00919">3</xref></contrib><contrib contrib-type="author"><name><surname>Russ</surname><given-names>Manuela</given-names></name><xref ref-type="aff" rid="af4-antioxidants-09-00919">4</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-8109-8235</contrib-id><name><surname>Mikkat</surname><given-names>Stefan</given-names></name><xref ref-type="aff" rid="af4-antioxidants-09-00919">4</xref><xref ref-type="aff" rid="af5-antioxidants-09-00919">5</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0001-9190-482X</contrib-id><name><surname>Glocker</surname><given-names>Michael Otto</given-names></name><xref ref-type="aff" rid="af4-antioxidants-09-00919">4</xref><xref rid="c1-antioxidants-09-00919" ref-type="corresp">*</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0001-6981-4174</contrib-id><name><surname>Hritcu</surname><given-names>Lucian</given-names></name><xref ref-type="aff" rid="af1-antioxidants-09-00919">1</xref><xref rid="c1-antioxidants-09-00919" ref-type="corresp">*</xref></contrib></contrib-group><aff id="af1-antioxidants-09-00919"><label>1</label>Department of Biology, Faculty of Biology, Alexandru Ioan Cuza University of Iasi, 700506 Iasi, Romania; <email>paula.postu@iroiasi.ro</email> (P.A.P.); <email>lucian.gorgan@uaic.ro</email> (D.L.G.)</aff><aff id="af2-antioxidants-09-00919"><label>2</label>Center for Fundamental Research and Experimental Development in Translation Medicine&#x02014;TRANSCEND, Regional Institute of Oncology, 700483 Iasi, Romania</aff><aff id="af3-antioxidants-09-00919"><label>3</label>Department of Pharmacognosy, Faculty of Pharmacy, &#x0201c;Grigore T. Popa&#x0201d; University of Medicine and Pharmacy, 700115 Iasi, Romania; <email>oana.cioanca@gmail.com</email></aff><aff id="af4-antioxidants-09-00919"><label>4</label>Proteome Center Rostock, Medical Faculty and Natural Science Faculty, University of Rostock, 18059 Rostock, Germany; <email>manuela.russ@med.uni-rostock.de</email> (M.R.); <email>stefan.mikkat@med.uni-rostock.de</email> (S.M.)</aff><aff id="af5-antioxidants-09-00919"><label>5</label>Core Facility Proteome Analysis, Rostock University Medical Center, D-18057 Rostock, Germany</aff><author-notes><corresp id="c1-antioxidants-09-00919"><label>*</label>Correspondence: <email>michael.glocker@med.uni-rostock.de</email> (M.O.G.); <email>hritcu@uaic.ro</email> (L.H.); Tel.: +49-381-494-4930 (M.O.G.); +40-232-201-666 (L.H.)</corresp></author-notes><pub-date pub-type="epub"><day>26</day><month>9</month><year>2020</year></pub-date><pub-date pub-type="collection"><month>10</month><year>2020</year></pub-date><volume>9</volume><issue>10</issue><elocation-id>919</elocation-id><history><date date-type="received"><day>27</day><month>8</month><year>2020</year></date><date date-type="accepted"><day>24</day><month>9</month><year>2020</year></date></history><permissions><copyright-statement>&#x000a9; 2020 by the authors.</copyright-statement><copyright-year>2020</copyright-year><license license-type="open-access"><license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p></license></permissions><abstract><p><italic>Origanum</italic> L. (Lamiaceae) is an important genus of medicinal and aromatic plants used in traditional medicine since ancient times as culinary herbs and remedies. The aim of the present study was to evaluate the chemical composition, as well as the biochemical and cellular activities of freshly prepared <italic>Origanum majorana</italic> L. essential oil (OmEO) in an Alzheimer&#x02019;s disease (AD) amyloid beta1-42 (A&#x003b2;1-42) rat model. OmEO (1% and 3%) was inhaled for 21 consecutive days, while A&#x003b2;1-42 was administered intracerebroventricularly to induce AD-like symptoms. Our data demonstrate that OmEO increased antioxidant activity and enhanced brain-derived neurotrophic factor (BDNF) expression, which in concert contributed to the improvement of cognitive function of animals. Moreover, OmEO presented beneficial effects on memory performance in Y-maze and radial arm-maze tests in the A&#x003b2;1-42 rat AD model.</p></abstract><kwd-group><kwd><italic>Origanum majorana</italic> L.</kwd><kwd>essential oil</kwd><kwd>amyloid beta peptide</kwd><kwd>memory</kwd><kwd>oxidative stress</kwd><kwd>proteome analysis</kwd><kwd>Alzheimer&#x02019;s disease</kwd></kwd-group></article-meta></front><body><sec sec-type="intro" id="sec1-antioxidants-09-00919"><title>1. Introduction</title><p>Aromatherapy is defined as the controlled use of concentrated essential oils extracted from herbs, flowers, and other plant parts for therapeutic or preventive purposes [<xref rid="B1-antioxidants-09-00919" ref-type="bibr">1</xref>]. The main routes of essential oils delivery are orally, dermally (aromatherapy massage) and olfactory administration (direct and indirect inhalation aromatherapy) [<xref rid="B2-antioxidants-09-00919" ref-type="bibr">2</xref>]. Essential oils are mainly known for pharmacological properties such as antifungal, antiviral, antimicrobial [<xref rid="B3-antioxidants-09-00919" ref-type="bibr">3</xref>], and antioxidant activity [<xref rid="B4-antioxidants-09-00919" ref-type="bibr">4</xref>]. In recent years, several authors have highlighted aromatherapy to be supportive in relieving pain [<xref rid="B5-antioxidants-09-00919" ref-type="bibr">5</xref>,<xref rid="B6-antioxidants-09-00919" ref-type="bibr">6</xref>,<xref rid="B7-antioxidants-09-00919" ref-type="bibr">7</xref>], reducing stress, and reinstalling emotional well-being [<xref rid="B8-antioxidants-09-00919" ref-type="bibr">8</xref>] and also with alleviating anxiety [<xref rid="B9-antioxidants-09-00919" ref-type="bibr">9</xref>] and depression [<xref rid="B10-antioxidants-09-00919" ref-type="bibr">10</xref>].</p><p><italic>Origanum majorana</italic> L. (Lamiaceae), commonly known as marjoram, is a herb native to the Mediterranean region and cultivated in many countries of Asia, North Africa, and Europe [<xref rid="B11-antioxidants-09-00919" ref-type="bibr">11</xref>]. Marjoram presents a strong and pleasant fragrance and is widely used as a spice. In folk medicine, this herb has been used as a remedy against various ailments such as asthma, indigestion, headache, and rheumatism [<xref rid="B12-antioxidants-09-00919" ref-type="bibr">12</xref>]. Different authors have reported marjoram&#x02019;s antibacterial and antiviral properties [<xref rid="B13-antioxidants-09-00919" ref-type="bibr">13</xref>,<xref rid="B14-antioxidants-09-00919" ref-type="bibr">14</xref>], antioxidant [<xref rid="B15-antioxidants-09-00919" ref-type="bibr">15</xref>] and anti-acetylcholinesterase (AChE) activities [<xref rid="B16-antioxidants-09-00919" ref-type="bibr">16</xref>], and also anti-metastatic and anti-tumor growth effects [<xref rid="B17-antioxidants-09-00919" ref-type="bibr">17</xref>]. Recently, a group of researchers demonstrated that <italic>Origanum majorana</italic> essential oil (OmEO) exerted antidepressant-like effects by modulating noradrenergic, dopaminergic, and serotonergic systems [<xref rid="B18-antioxidants-09-00919" ref-type="bibr">18</xref>]. Another group of researchers showed that OmEO alleviated anxiety in bruxistic patients and claimed that this essential oil might represent a safe alternative for benzodiazepine treatment [<xref rid="B19-antioxidants-09-00919" ref-type="bibr">19</xref>]. Moreover, <italic>O. majorana</italic> possesses anti-inflammatory properties [<xref rid="B20-antioxidants-09-00919" ref-type="bibr">20</xref>]. An in vitro study performed by Arranz et al. [<xref rid="B21-antioxidants-09-00919" ref-type="bibr">21</xref>] revealed that OmEO exerts anti-inflammatory activity through the inhibition of pro-inflammatory cytokine secretion, such as tumor necrosis factor-alpha (TNF-&#x003b1;), interleukin 1&#x003b2; (IL-1&#x003b2;), and interleukin 6 (IL-6) in activated macrophages.</p><p>Amyloidosis is a condition characterized by the deposition of insoluble proteins in the extracellular space of various tissues. The most frequent types of amyloidosis are related to amyloid &#x003b2; (A&#x003b2;) deposition, which is characteristic of neurological conditions such as aging, traumatic brain injuries, or AD [<xref rid="B22-antioxidants-09-00919" ref-type="bibr">22</xref>]. A&#x003b2; peptide is an internal processing product generated through serial proteolytic cleavages of the amyloid precursor protein (APP) [<xref rid="B23-antioxidants-09-00919" ref-type="bibr">23</xref>,<xref rid="B24-antioxidants-09-00919" ref-type="bibr">24</xref>]. In humans, the soluble form of this peptide is produced and released in low amounts during normal cellular activity, and it was shown to be beneficial for normal brain synaptic activity in the absence of neurotoxicity [<xref rid="B25-antioxidants-09-00919" ref-type="bibr">25</xref>]. Moreover, the picomolar range concentrations of synthetic A&#x003b2;1-42 positively affect the synaptic transmission in vivo. Yet, nanomolar range concentrations of A&#x003b2;1-42 appear to be neurotoxic, involving detrimental effects as impairment of synaptic transmission [<xref rid="B26-antioxidants-09-00919" ref-type="bibr">26</xref>,<xref rid="B27-antioxidants-09-00919" ref-type="bibr">27</xref>]. The mechanism underlying A&#x003b2;&#x02013;mediated synaptic dysfunctions is still unclear, but it may be related to the reduction of postsynaptic density protein 95 (PSD95) levels and negative regulation of &#x003b1;-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) and N-methyl-D-aspartate (NMDA) glutamatergic receptors [<xref rid="B28-antioxidants-09-00919" ref-type="bibr">28</xref>]. A&#x003b2; also contributes to BDNF signaling disruption, impairing neuronal plasticity, thus affecting learning and memory processes [<xref rid="B29-antioxidants-09-00919" ref-type="bibr">29</xref>]. Furthermore, A&#x003b2; mediates the generation of reactive oxygen species (ROS) that rapidly react with lipids, proteins, or deoxyribonucleic acids (DNA) determining lipid peroxidation, protein, and DNA oxidation [<xref rid="B30-antioxidants-09-00919" ref-type="bibr">30</xref>]. Besides, the A&#x003b2; peptide induces inflammatory responses through microglial cell activation leading to the release of pro-inflammatory cytokines, which may increase neuronal degeneration and neuronal synapses loss [<xref rid="B31-antioxidants-09-00919" ref-type="bibr">31</xref>,<xref rid="B32-antioxidants-09-00919" ref-type="bibr">32</xref>].</p><p>In this study, an amyloidosis rat model was used in an attempt to demonstrate the memory-enhancing effects of OmEO, which, because of the A&#x003b2;1-42-related perturbation, may be clearer to determine, as opposed to studying non-challenged animals.</p></sec><sec id="sec2-antioxidants-09-00919"><title>2. Materials and Methods</title><sec id="sec2dot1-antioxidants-09-00919"><title>2.1. Plant Material</title><p>The aerial flowering parts of <italic>Origanum majorana</italic> L. (Lamiaceae) were collected during August 2019 from green crops within the Agricultural Research and Development Unit of Secuieni, Neamt County, Romania. A voucher specimen was botanically authenticated and preserved for ready reference at the Department of Pharmacognosy, Faculty of Pharmacy, University of Medicine and Pharmacy &#x0201c;Gr. T. Popa&#x0201d;, Iasi, Romania. The essential oil was obtained through 3 h hydro-distillation of fresh plant material using a Clevenger type equipment. Anhydrous sodium sulfate was used to dry the essential oil, removing the water from the distillate. It was then stored in amber vials at a temperature of 4 &#x000b0;C for further examination. The essential oil extraction yield was 0.34% (<italic>v</italic>/<italic>v</italic>).</p></sec><sec id="sec2dot2-antioxidants-09-00919"><title>2.2. Gas Chromatography-Mass Spectrometry (GC-MS) Analysis</title><p>The analysis of the essential oil was done using a gas chromatograph (Agilent 6890N, Agilent Technologies, Santa Clara, CA, USA) with 5975 inert XL mass selective detector (Agilent Technologies, Santa Clara, CA, USA) and flame ionization detector (GC-FID) equipped with a 30 m &#x000d7; 0.25 mm &#x000d7; 0.25 &#x003bc;m column (5%-phenyl)-methylpolysiloxane (HP 5MS, Agilent Technologies, Santa Clara, CA, USA); the injector temperature was 250&#x02013;280 &#x000b0;C; increasing 4 grades/min; as mobile phase was used helium 1mL/min; split ratio 1:100; sample volume 0.2 &#x000b5;L. The retention indices (RI) were calculated against hydrocarbon (C4&#x02013;C40) standards. Identification of the essential compounds was carried out by comparing retention times (RT), retention indices (RI), and mass spectra with those obtained from Wiley libraries [<xref rid="B33-antioxidants-09-00919" ref-type="bibr">33</xref>].</p></sec><sec id="sec2dot3-antioxidants-09-00919"><title>2.3. Animals</title><p>Twenty-eight adult male Wistar rats were purchased from Cantacuzino Institute (Bucharest, Romania) with an average weight of 250 g (&#x000b1;80 g) and an age of 3 months. Animals were housed in 1500 U polysulfone cages (480 &#x000d7; 325 &#x000d7; 210 mm) (Tecniplast, Buguggiate, Italy) under standard laboratory conditions (22 &#x000b0;C room temperature, 12 h light/12 h dark cycle) with ad libitum access to water and food. All animal experiments were carried out according to the European Communities Council Directive (Directive 2010/63/EU) as well as the &#x0201c;Principles of Laboratory Animal Care&#x0201d; (NIH publication No. 85-23) concerning the protection of animals used for scientific and experimental purposes with approval of the Ethical Committee (No. 15309/22.07.2019).</p></sec><sec id="sec2dot4-antioxidants-09-00919"><title>2.4. Experimental Protocol for Generating the AD Rat Model</title><p>Rats were anesthetized by intraperitoneal (i.p.) injection of the sodium pentobarbital solution (50 mg/kg, b.w., i.p., Sigma-Aldrich, Darmstadt, Germany) and mounted in a stereotaxic device. An iodine solution (10%, Hach, Loveland, CO, USA) was used to wash the scalp of the animals before midline incision, and then a thin hole (0.75 mm diameter) was drilled (Parkside Microdrill, Germany) in the skull 1.5 mm unilaterally right from the bregma craniometric point. To induce the AD rat model as previously described [<xref rid="B34-antioxidants-09-00919" ref-type="bibr">34</xref>], A&#x003b2;1-42-containing solution (1 mM, Sigma-Aldrich, Darmstadt, Germany, dissolved in 0.9% sterile saline solution) was incubated at 37 &#x000b0;C for 4 days (<xref ref-type="fig" rid="antioxidants-09-00919-f001">Figure 1</xref>: day 4). Afterward, a volume of 4 &#x003bc;L of A&#x003b2;1-42 solution was intracerebroventricularly (i.c.v.) delivered for 4 min (flow rate 1 &#x003bc;L/min) by a Hamilton microsyringe 7.4 mm ventral from the surface of the cortex, according to the stereotaxic atlas (<xref ref-type="fig" rid="antioxidants-09-00919-f001">Figure 1</xref>: day 0) [<xref rid="B35-antioxidants-09-00919" ref-type="bibr">35</xref>]. The syringe needle was left in place for another 5 min before being slowly removed. The control animals (sham-operated rats) received 4 &#x003bc;L of 0.9% sterile saline solution instead of the A&#x003b2;1-42 solution. Finally, the incisions were sutured, and the animals received a wide-spectrum antibiotic (as powder that was spread along the suture) before being returned to their home cages to recover. Postoperatively, the animals were individually housed in cages for 3 days for incision healing (<xref ref-type="fig" rid="antioxidants-09-00919-f001">Figure 1</xref>), having free access to water and food.</p></sec><sec id="sec2dot5-antioxidants-09-00919"><title>2.5. Drug Treatment and Experimental Design</title><p>The rats were divided into 4 groups (<italic>n</italic> = 7 animals/group): the control group (sham-operated) (I), the A&#x003b2;1-42 (1 mM, Sigma-Aldrich, Darmstadt, Germany), alone-treated group (II), and the A&#x003b2;1-42 receiving OmEO by inhalation groups (A&#x003b2;1-42+ 1%OmEO (III) and A&#x003b2;1-42+ 3%OmEO (IV)). InVivoStat and R-based statistical packages were used to confirm that <italic>n</italic> = 7 animals per group is appropriate [<xref rid="B36-antioxidants-09-00919" ref-type="bibr">36</xref>]. Moreover, considering a significance level of 0.05, the power to detect a 20% biologically relevant change from control is 93%. Sham and A&#x003b2;1-42 groups received 1% Tween 80 solution through inhalation. OmEO was diluted with 1% Tween 80 (<italic>v</italic>/<italic>v</italic>). OmEO exposure (200 &#x003bc;L, either 1% or 3%) was via an electronic vaporizer (KBAYBO, China). Rats were treated by inhalation with OmEO (1% and 3%), which started at day 5 post-surgery (<xref ref-type="fig" rid="antioxidants-09-00919-f001">Figure 1</xref>) and lasted till the end of the behavioral tests (21 days), for 15 min each day. As for the concentrations indicated in the pharmacological tests, 1% essential oil, commonly used in aromatherapy, and a concentration of 3% were used to increase the effects, as we previously stated [<xref rid="B34-antioxidants-09-00919" ref-type="bibr">34</xref>]. On day 27 (<xref ref-type="fig" rid="antioxidants-09-00919-f001">Figure 1</xref>), all the rats were euthanized with overdoses of sodium pentobarbital (150 mg/kg, b.w., i.p., Sigma-Aldrich, Darmstadt, Germany) and brain regions were excised on ice. From three randomly selected rats per group, the excised hippocampi were collected in RNA Save solution (Biological Industries, Beit-Haemek, Israel) and stored at &#x02212;80 &#x000b0;C for further RNA isolation and qRT-PCR analysis. From the other three randomly selected rats per group, the excised hippocampi were immediately stored at &#x02212;20 &#x000b0;C for further biochemical parameter assessments. From the remaining one rat per group, the hippocampi and the surrounding cerebral cortices were excised and immediately stored at &#x02212;80 &#x000b0;C for proteome analysis (for surgery details, see <xref ref-type="app" rid="app1-antioxidants-09-00919">Supplemental File 1</xref>).</p></sec><sec id="sec2dot6-antioxidants-09-00919"><title>2.6. Biochemical Parameters Assay</title><p>For the assay of the biochemical parameters, the frozen hippocampi were allowed to thaw for 2 min at room temperature upon which they were individually homogenized (1:10) in ice-cold 0.1 M potassium phosphate buffer (pH 7.4), 1.15% KCl by using a Potter Homogenizer (Cole-Parmer, Vernon Hills, IL, USA). The homogenates were centrifuged at 960&#x000d7; <italic>g</italic> for 15 min at 4 &#x000b0;C. The supernatant was used for the estimation of protein carbonyl and malondialdehyde (MDA) levels following the methods described [<xref rid="B34-antioxidants-09-00919" ref-type="bibr">34</xref>]. The total protein content was determined using a bicinchoninic acid (BCA) protein assay kit (Sigma-Aldrich, Darmstadt, Germany) according to a method previously described [<xref rid="B37-antioxidants-09-00919" ref-type="bibr">37</xref>].</p></sec><sec id="sec2dot7-antioxidants-09-00919"><title>2.7. Apoptotic State Evaluation</title><p>A cell death detection ELISA kit (Roche Diagnostics, Mannheim, Germany) was used for quantification of histone-associated DNA fragments. Following the protocol provided by the manufacturer, the reconstituted biotinylated anti-histone antibody was incubated for 1 h and then washed from the microplate (MP) module. For the non-specific binding sites blocking, the incubation solution was added on the MP module and kept for 30 min. Following a washing step, the sample solution, containing 1:20 dilution of the centrifuged hippocampal homogenate prepared for biochemical assays, was incubated on MP module for 1 h and 30 min. Then, the sample solution was washed, and the reconstituted anti-DNA- peroxidase (POD) antibody was incubated for 1 h and 30 min. Following the washing of unbound anti-DNA-POD antibody, the substrate solution was added on the MP module and incubated on a shaker plate for 10 min. The POD retained in the imunocomplex was photometrically determined using a microplate reader (BioTek, Winooski, VT, USA). The enrichment factor, reflecting n-fold apoptosis, was calculated as the absorbance of the sample/absorbance of negative control, where the negative control was represented by the sham-operated rats.</p></sec><sec id="sec2dot8-antioxidants-09-00919"><title>2.8. RNA Isolation and Hippocampal Real-Time Quantitative PCR (qRT-PCR)</title><p>The hippocampi stored in RNA Save solution in frozen state were allowed to thaw for 2 min at room temperature and 45 mg from each hippocampus was collected. For the collected hippocampal tissues, SV Total RNA Isolation System kit (Promega, Madison, WI, USA) was applied in order to isolate and purify the total ribonucleic acid (RNA), according to the manufacturer&#x02019;s instructions and the protocol previously described [<xref rid="B38-antioxidants-09-00919" ref-type="bibr">38</xref>]. For quantifying the expression of genes of interest, reverse transcription and amplification by real-time quantitative PCR (RT-qPCR) were performed using a GoTaq<sup>&#x000ae;</sup> 1-Step RT-qPCR System (Promega, Madison, WI, USA) on a 5-plex HRM Rotor-Gene 6000 (Corbett, CA, USA) real-time PCR. The reaction mixture contained 10 &#x000b5;L GoTaq<sup>&#x000ae;</sup> Probe qPCR Master Mix (1X) (Promega, Madison, WI, USA), 0.4 &#x000b5;L GoScript&#x02122; RT Mix for 1-Step RT-qPCR (50&#x000d7;), 2&#x000b5;L Forward primer, 2&#x000b5;L Reverse primer, 4 &#x000b5;L RNA solution, and 1.6 &#x000b5;L Nuclease-Free Water.</p><p>For the absolute quantification of two transcripts, BDNF and IL1&#x003b2;, primers with the following sequences were used: BDNF forward and reverse primer (F: 5&#x02032;-ATT ACC TGG ATG CCG CAA AC-3&#x02032;; R: 5&#x02032;-TGA CCC ACT CGC TAA TAC TGT-3&#x02032;, 101 bp product size) (M98820.1); IL1&#x003b2; forward and reverse primer (F: 5&#x02032;- AGC ACC TTC TTT TCC TTC ATC TT-3&#x02032;, R: 5&#x02032;-CAG ACA GCA GGC ATT TT-3&#x02032;, 144 bp product size) (M61178.1). The reaction thermic profile consisted of reverse transcription step&#x02014;15 min (37 &#x000b0;C); RT inactivation/Hot-Start activation&#x02014;10 min (95 &#x000b0;C); 40 cycles of 3-step qPCR: 10 s (95 &#x000b0;C)&#x02014;denaturation, 30 s (60 &#x000b0;C)&#x02014;alignment and data collection (Green channel&#x02014;BRYT Green<sup>&#x000ae;</sup> dye, Madison, WI, USA), 30 s (72 &#x000b0;C)&#x02014;elongation; and dissociation step (from 60&#x02013;95 &#x000b0;C). Rotor-Gene Q-Pure Detection Software v. 2.2.3. (Qiagen, CA, USA) was used for absolute quantification of BDNF and IL1&#x003b2; expression levels.</p></sec><sec id="sec2dot9-antioxidants-09-00919"><title>2.9. Proteomics Pilot Experiment</title><sec id="sec2dot9dot1-antioxidants-09-00919"><title>2.9.1. Generation of Peptide Solutions for Proteome Analysis</title><p>Three pieces of frozen brain tissue containing the hippocampi (between 238 mg and 321 mg) were used to produce crude protein extracts. Each piece was from one specimen, to represent the experimental groups A&#x003b2; (1&#x02013;42) (II), A&#x003b2; (1&#x02013;42) + 1%OmEO (III), and A&#x003b2; (1&#x02013;42) + 3%OmEO (IV). Each frozen brain tissue piece was thawed for 2 min at room temperature, weighed, and wetted with lysis buffer consisting of 1% sodium deoxycholate (SDC), 20 mM dithiothreitol (DTT) in 50 mM ammonium bicarbonate (ABC) and protease inhibitor cocktail Complete<sup>TM</sup> (Roche, Mannheim, Germany) [<xref rid="B39-antioxidants-09-00919" ref-type="bibr">39</xref>]. The added volume of lysis buffer (in &#x000b5;L) with respect to brain tissue weight (in mg) was in the 9:1 ratio, as described [<xref rid="B40-antioxidants-09-00919" ref-type="bibr">40</xref>]. Brain tissue pieces and lysis buffer mixtures were transferred into a dounce homogenizer (Kontes Glass Co, Vineland, NJ, USA), and tissues were disrupted within 10 passes. To complete homogenization, suspensions were transferred into new 15 mL Falcon tubes, heated at 95 &#x000b0;C for 5 min in a water bath, followed by double ultra-sonication (Sonorex Super RK 31H, BANDELIN, Berlin, Germany), each for 15 s, interrupted for 2 min. Then, 50 mM ABC was added to each suspension in the same volume as the respective lysis buffer volume to reach a final concentration of 0.5% SDC. Next, the extracts were shaken for 10 min at room temperature and centrifuged at 16,000&#x000d7; <italic>g</italic> for 10 min at 20 &#x000b0;C. After centrifugation, the supernatants (crude protein extracts; volumes were between 4 mL and 6 mL) were aliquoted into 0.5 mL portions and transferred into new 1.5 mL Eppendorf tubes. For protein concentration determination, Bradford assay was used as described [<xref rid="B41-antioxidants-09-00919" ref-type="bibr">41</xref>], due to its compatibility with reducing agents, such as DTT. Taking aliquots of crude protein extracts (300 &#x000b5;L to 400 &#x000b5;L), the reduced proteins (1 mg, each) were alkylated at room temperature in the dark for 20 min by adding 9 &#x000b5;L to 12 &#x000b5;L of 0.5 M iodoacetamide solution, dissolved in 50 mM ABC. The digestion of reduced and alkylated proteins was then performed overnight at 37 &#x000b0;C by adding 100 &#x000b5;L of trypsin solution (Promega, Madison, WI, USA; dissolved in 50 mM ABC) with an enzyme to substrate ratio of 1:100 (<italic>w</italic>/<italic>w</italic>). After digestion, peptide mixtures were centrifuged, supernatants (300 &#x000b5;L to 400 &#x000b5;L) were collected in separate 2 mL Eppendorf tubes, and phase transfer-assisted removal of SDC [<xref rid="B42-antioxidants-09-00919" ref-type="bibr">42</xref>] was performed as previously described [<xref rid="B43-antioxidants-09-00919" ref-type="bibr">43</xref>]. Ethyl acetate (in the same volume as the volume of the respective peptide mixture) and 25% trifluoroacetic acid (1/50 of the respective ethyl acetate volume) were added. The peptide mixtures were rigorously shaken for 2 min and subsequently centrifuged at 12,000&#x000d7; <italic>g</italic> for 10 min to obtain aqueous and organic phases. The aqueous phase of each peptide mixture was collected using a gel loading tip and reduced in volume to final volume of around 100 &#x000b5;L, each using a centrifugal evaporator (Speedvac RVC 2-25 CD plus, Martin Christ GmbH, Osterode am Harz, Germany). The peptide concentrations were measured using the Qubit assay as described [<xref rid="B44-antioxidants-09-00919" ref-type="bibr">44</xref>], followed by desalting with OASIS cartridges [<xref rid="B45-antioxidants-09-00919" ref-type="bibr">45</xref>]. Peptide concentrations of desalted peptide solutions were measured using the Qubit assay [<xref rid="B44-antioxidants-09-00919" ref-type="bibr">44</xref>].</p></sec><sec id="sec2dot9dot2-antioxidants-09-00919"><title>2.9.2. Mass Spectrometric Proteome Analysis</title><p>Mass spectrometric analysis of peptide mixtures was performed in duplicate on a Synapt G2S mass spectrometer (Waters, Manchester, UK) using Masslynx version 4.1, coupled to a nanoAcquity UPLC system (Waters, Manchester, UK) via a NanoLockSpray ion source using a PicoTip Emitter (New Objective, Woburn, MA, USA) as described [<xref rid="B41-antioxidants-09-00919" ref-type="bibr">41</xref>,<xref rid="B46-antioxidants-09-00919" ref-type="bibr">46</xref>]. Mobile phase A contained 0.1% formic acid in water, and mobile phase B contained 0.1% formic acid in acetonitrile. Peptide solutions containing approx. 70 ng of peptides were supplemented with 40 fmol of Hi3 ClpB_ECOLI standard (Waters, Manchester, UK) for absolute quantitation. Peptides were trapped and desalted using a precolumn (nanoACQUITY UPLC Symmetry C18, 5 &#x000b5;m, 180 &#x000b5;m &#x000d7; 20 mm) (Waters, Manchester, UK) at a flow rate of 10 &#x000b5;L/min for 4 min with 99.9% A. Peptides were separated on an analytical column (ACQUITY UPLC HSS T3, 1.8 &#x000b5;m, 75 &#x000b5;m &#x000d7; 200 mm) (Waters, Manchester, UK) at a flow rate of 300 nL/min using a gradient from 3% to 35% B over 120 min. As a reference compound, 100 fmol/&#x003bc;L [Glu1]-fibrinopeptide B was delivered at 500 nL/min to the reference sprayer of the NanoLockSpray source. The SYNAPT G2S instrument was operated in a data-independent mode [<xref rid="B47-antioxidants-09-00919" ref-type="bibr">47</xref>], characterized by parallel fragmentation of multiple precursor ions in combination with ion-mobility separation as an additional dimension of separation (referred to as HDMS<sup>E</sup>) [<xref rid="B48-antioxidants-09-00919" ref-type="bibr">48</xref>]. By executing alternate scans at low and elevated collision energy (CE) of each 0.5 s, information on precursor and fragment ions, respectively, was acquired. In low-energy MS mode, acquisitions were performed at constant CE of 4 eV, whereas drift time-dependent CE settings were applied in elevated-energy MS mode. The values of drift time-dependent CE settings were used as described [<xref rid="B49-antioxidants-09-00919" ref-type="bibr">49</xref>]. Lock spray was acquired once every 30 s for a 1 s period. Mass spectrometric data were stored as raw data files.</p></sec><sec id="sec2dot9dot3-antioxidants-09-00919"><title>2.9.3. Database Assembly and Proteome Data Analysis</title><p>For the database search, a database containing 29,944 protein sequences of the <italic>Rattus norvegicus</italic> proteome (<uri xlink:href="http://www.uniprot.org/">http://www.uniprot.org/</uri>; UniProt release 2020_06) appended with the sequences of ClpB_ECOLI (P63284) and porcine trypsin was used. Mass spectrometric raw data file processing, protein identification, and label-free quantification of identified proteins were performed using the Progenesis QI for Proteomics software package, version 4.1 (Nonlinear Dynamics, Newcastle upon Tyne, UK) as previously described [<xref rid="B46-antioxidants-09-00919" ref-type="bibr">46</xref>]. The following search parameters were set: trypsin as digestion reagent, two missing cleavage sites allowed, carbamidomethylation of cysteines as a fixed modification, and oxidation of methionine residues as variable modification. The false discovery rate was set to 1%. At least three fragment ions were required for peptide identification, and at least six fragment ions corresponding to minimally two peptides were required for protein identification. Moreover, for peptide identifications, only peptides with two, three, and four positive charges were accepted if they were identified in at least two of the six measurement series. In addition, the peptides with a peptide score below 5.7, absolute mass error above 13 ppm, and less than 6 amino acid residues in length were excluded.</p><p>The mass spectrometry proteomic data have been deposited to the ProteomeXchange Consortium via the PRIDE [<xref rid="B50-antioxidants-09-00919" ref-type="bibr">50</xref>] partner repository with the dataset identifier PXD021082.</p></sec></sec><sec id="sec2dot10-antioxidants-09-00919"><title>2.10. Behavioral Analysis</title><sec id="sec2dot10dot1-antioxidants-09-00919"><title>2.10.1. Y-maze</title><p>Spontaneous alternation behavior and hippocampus integrity were assessed through a single session Y-maze as previously described [<xref rid="B51-antioxidants-09-00919" ref-type="bibr">51</xref>,<xref rid="B52-antioxidants-09-00919" ref-type="bibr">52</xref>]. The Y-maze used in the present study was constructed of Plexiglas with the following dimensions: 25 cm high, 35 cm long, 10 cm wide of each arm, and an equilateral triangular central area. Fourteen days post-surgery (<xref ref-type="fig" rid="antioxidants-09-00919-f001">Figure 1</xref>) and 15 min from OmEO (1% and 3%) inhalation session, each animal was placed at the end of an arm and allowed to explore the maze for 8 min. Successive entry in each arm was interpreted as behavioral alternation. A blinded observer registered visited arms sequence corresponding to each animal. The spontaneous alternation percentage was calculated as (number of alternation/total entries &#x02212; 2) &#x000d7; 100. Between trials, the Y-maze was washed with a 10% ethanol solution.</p></sec><sec id="sec2dot10dot2-antioxidants-09-00919"><title>2.10.2. Radial Arm Maze</title><p>Spatial memory performance was assessed through radial arm maze (RAM) as previously described [<xref rid="B53-antioxidants-09-00919" ref-type="bibr">53</xref>]. Before the start of the test, the animals were subjected to a weight loss regime, until the body weight of the animals represented 85% of the initial weight. The food restriction represents an essential factor for an efficient arm-choice within RAM [<xref rid="B54-antioxidants-09-00919" ref-type="bibr">54</xref>] and it has been shown that food-deprived rats performed RAM more efficiently than food-undeprived rats [<xref rid="B55-antioxidants-09-00919" ref-type="bibr">55</xref>]. Despite restrictive access to food, the animals had free access to water. The maze comprising eight arms marked from 1 to 8 (48 cm &#x000d7; 12 cm), with a radial extension of 32 cm in diameter from the central area, had 50 mg food pellet at the end of arms 1, 2, 4, 5, and 7. The RAM was started on day 16 (<xref ref-type="fig" rid="antioxidants-09-00919-f001">Figure 1</xref>) and performed in two stages: a training stage (4 consecutive days) aimed at habituation and a testing stage (7 successive days). Each training session lasted 5 min, with groups of 3 or 4 animals being tested. Although in the training days, the food baits were spread all over the maze, in test days, only 5 arms contained baits placed at the end of each arm. To perform the test, each animal was centrally positioned in the maze allowing it to explore the maze and consume the baits from the 5 arms. Behavioral assessment was completed when the animal consumed all 5 baits or after 5 min. An animal was considered to have entered an arm when all four of its members were in that arm. For working memory and reference memory tasks, each rat was individually placed in the center of the maze 15 min after inhaling OmEO (1% and 3%). Determinations were carried out by (i) assessing the number of working memory errors (getting inside an arm that contains food pellet, but earlier stepped into) and (ii) calculating the number of reference memory errors (calculating animal enters in an arm without food pellet). Spatial working memory represents the ability to hold process-specific information for a while, so that spatial responses can be performed flexibly from process to process. This type of memory is the basis of feeding behavior; thus, the subject remembering the arm just visited can adopt an effective search strategy. Spatial reference memory is represented by the ability to learn a consistent, fixed response to a spatial stimulus, being reflected by a constant association between the respective spatial location and an outcome. Thus, the animal will have to learn the position of the three arms not reinforced with baits, these remaining constant [<xref rid="B56-antioxidants-09-00919" ref-type="bibr">56</xref>]. Between trials, the radial arm maze was washed with a 10% ethanol solution.</p></sec></sec><sec id="sec2dot11-antioxidants-09-00919"><title>2.11. Statistical Analysis</title><p>All data are expressed as the mean &#x000b1; standard error of the mean (S.E.M.). GraphPad Prism 8.0 (GraphPad Software, Inc., San Diego, CA, USA) was used to perform statistical analyses through a one-way analysis of variance (ANOVA) followed by Tukey&#x02019;s <italic>post hoc</italic> multiple comparison test, considering treatment as a factor. A <italic>p</italic>-value of &#x0003c; 0.05 was considered significant. For protein analysis, Origin Pro 2016 (Originlab Co, MA, USA) and Excel methods of calculation were used.</p></sec></sec><sec sec-type="results" id="sec3-antioxidants-09-00919"><title>3. Results and Discussions</title><sec id="sec3dot1-antioxidants-09-00919"><title>3.1. Phytochemical Profile of the Origanum Majorana Essential Oil</title><p>Using GC-FID and GC-MS, 37 chemical compounds were identified in the freshly prepared OmEO (altogether, about 94.34% of the volatiles) (<xref ref-type="app" rid="app1-antioxidants-09-00919">Supplemental File 2</xref>). The chemical constituents identified included monoterpenes (90.42%), whereas sesquiterpenes (7.92%) were minor components. The analysis of OmEO showed terpinen-4-ol (23.52%), sabinene (12.59%), terpinolene (8.72%), linalool (5.94%), &#x003b2;-thujene (4.60%), phellandrene (4.35%), and &#x003b1;-terpineol (4.30%) as the most abundant volatile components. Based on these findings, our essential oil exhibits a chemical composition equal to those documented by other authors [<xref rid="B57-antioxidants-09-00919" ref-type="bibr">57</xref>,<xref rid="B58-antioxidants-09-00919" ref-type="bibr">58</xref>,<xref rid="B59-antioxidants-09-00919" ref-type="bibr">59</xref>,<xref rid="B60-antioxidants-09-00919" ref-type="bibr">60</xref>].</p></sec><sec id="sec3dot2-antioxidants-09-00919"><title>3.2. Proteome Analysis of the Rat Brains Containing Hippocampi</title><p>For this project, a data-driven research approach was followed using proteomics to generate an overview regarding the potential molecular effects of OmEO therapy, instead of a solely theory- or hypothesis-driven research approach [<xref rid="B61-antioxidants-09-00919" ref-type="bibr">61</xref>]. Initially, 1224 proteins were identified in the rat brain tissue containing hippocampi (<xref ref-type="app" rid="app1-antioxidants-09-00919">Supplemental File 3</xref>), which were ranked according to their relative abundances in the A&#x003b2;1-42 group (II) (<xref ref-type="fig" rid="antioxidants-09-00919-f002">Figure 2</xref>). Next, abundance profiles of the A&#x003b2;1-42 and 1%OmEO (III) and A&#x003b2;1-42 and 3%OmEO (IV) were superimposed to visualize abundance differences. Abundance differences were categorized by the 2&#x000d7; threshold line and the 3&#x000d7; threshold line, respectively. The most abundant 25 proteins and the least abundant 25 proteins were excluded from abundance comparisons.</p><p>It is tempting to regard the proteins above and below the 2&#x000d7; and 3&#x000d7; threshold lines as being of potential interest (<xref ref-type="fig" rid="antioxidants-09-00919-f002">Figure 2</xref>). However, considering the low number of animals per group, the abundance differences of those particular proteins should not be overemphasized, as statistical significance cannot be reached. Instead, the listed proteins in sum seemed to point to respective pathways/biological processes of interest, which then were tested for their potential roles with regard to OmEO-related effects by applying well-established functional assays (<xref rid="antioxidants-09-00919-t001" ref-type="table">Table 1</xref>).</p><p>From the 17 proteins whose expression seemed influenced by OmEO administration (<xref rid="antioxidants-09-00919-t001" ref-type="table">Table 1</xref>), 10 were regarded as representatives of biological processes, such as cognitive function, apoptosis, neuroinflammation, and oxidative stress, respectively. These biological functions were further targeted using well established biochemical/molecular assays one after the other (see below). The protein with the accession number Q5XIU9 is involved in adipose tissue development and, although <italic>Origanum majorana</italic> extract proved to be efficient in modulating lipid accumulation in liver and kidneys [<xref rid="B63-antioxidants-09-00919" ref-type="bibr">63</xref>], we did not further assess this protein&#x02019;s function since the biological process in which it is involved in was not the focus of this study. The remaining six proteins (Q08163, M0RBL8, P31232, P84083, Q5M821, and P01835) were assigned by Funrich to biological processes, such as energy consumption or cell motility. Although they indicated cellular activity in general, e.g., associated with healing processes and cellular regeneration, these functions were not further investigated.</p></sec><sec id="sec3dot3-antioxidants-09-00919"><title>3.3. Differential Activities of Biological Processes Determined by Functional Assays</title><sec id="sec3dot3dot1-antioxidants-09-00919"><title>3.3.1. Neuroinflammation</title><p>Since the nuclear factor kappa-B (NF-&#x003ba;B) regulates transcription of a cohort of genes implicated in immune and inflammatory responses [<xref rid="B64-antioxidants-09-00919" ref-type="bibr">64</xref>] and its activation involves three major signaling pathways: (i) the canonical pathway, triggered by TNF&#x003b1; or IL-1; (ii) the non-canonical pathway, elicited by CD40 ligand or lymphotoxin &#x003b2;; and (iii) atypical signaling pathways, initiated by DNA-damage [<xref rid="B65-antioxidants-09-00919" ref-type="bibr">65</xref>], its role in neuroinflammatory processes [<xref rid="B66-antioxidants-09-00919" ref-type="bibr">66</xref>] was of interest. IL-1&#x003b2; is a crucial mediator of inflammatory responses [<xref rid="B67-antioxidants-09-00919" ref-type="bibr">67</xref>], and its quantification by RT-qPCR was regarded as the method of choice [<xref rid="B68-antioxidants-09-00919" ref-type="bibr">68</xref>].</p><p>IL-1&#x003b2; mRNA copy numbers, which are related to inflammatory processes, were found significantly overexpressed in the A&#x003b2;1-42 pretreated group (II) vs. the sham-operated group (I) (<italic>p</italic> = 0.0032) (<xref ref-type="fig" rid="antioxidants-09-00919-f003">Figure 3</xref>). Yet, the inhaled OmEO attenuated only slightly the inflammatory response observed in A&#x003b2;1-42-pretreated rats, the minor changes induced by both concentrations of OmEO being statistically insignificant (<italic>p</italic> = 0.1107 for 1%OmEO (III) and <italic>p</italic> = 0.0635 for 3%OmEO (IV), respectively).</p><p>The IL-1&#x003b2; overexpression in response to experimentally induced neurotoxic stimuli is well documented [<xref rid="B69-antioxidants-09-00919" ref-type="bibr">69</xref>]; thus, the increased expression of IL-1&#x003b2; induced by A&#x003b2;1-42 stands in general agreement with previous results. Furthermore, anti-inflammatory properties of OmEO were already mentioned in literature and sustained by in vitro studies [<xref rid="B21-antioxidants-09-00919" ref-type="bibr">21</xref>]. Yet, our in vivo study found the potential of OmEO to reduce inflammation to be questionable as statistical significance was not reached.</p></sec><sec id="sec3dot3dot2-antioxidants-09-00919"><title>3.3.2. Apoptosis</title><p>NF-&#x003ba;B is generally regarded as being anti-apoptotic. Yet, in certain contexts, NF-&#x003ba;B may as well act as a promotor of apoptosis, especially in response to cellular stress [<xref rid="B70-antioxidants-09-00919" ref-type="bibr">70</xref>,<xref rid="B71-antioxidants-09-00919" ref-type="bibr">71</xref>]. To test whether apoptosis was a biological process with significance to OmEO treatment-related effects, apoptosis was investigated using a specific cell death detection ELISA assay, as was previously demonstrated [<xref rid="B72-antioxidants-09-00919" ref-type="bibr">72</xref>,<xref rid="B73-antioxidants-09-00919" ref-type="bibr">73</xref>,<xref rid="B74-antioxidants-09-00919" ref-type="bibr">74</xref>].</p><p>DNA fragmentation, associated to apoptotic processes, was found significantly elevated in the A&#x003b2;1-42 pretreated group (II) vs. the sham-operated group (I) (<italic>p</italic> = 0.0008) (<xref ref-type="fig" rid="antioxidants-09-00919-f004">Figure 4</xref>). Yet, OmEO inhalation determined only moderated reductions of DNA fragmentation (<italic>p</italic> = 0.0634 for 1%OmEO (III) and <italic>p</italic> = 0.1059 for 3%OmEO (IV), respectively).</p><p>Brain DNA damage naturally occurs during aging and exacerbates in different pathologies, such as AD. As shown in this study, A&#x003b2;1-42 administered to rats determined increased DNA fragmentation, indicating increased apoptosis. However, the specific intracellular signaling pathways by which A&#x003b2; triggers the apoptotic processes are poorly defined, even though several pathways were already proposed [<xref rid="B75-antioxidants-09-00919" ref-type="bibr">75</xref>,<xref rid="B76-antioxidants-09-00919" ref-type="bibr">76</xref>,<xref rid="B77-antioxidants-09-00919" ref-type="bibr">77</xref>,<xref rid="B78-antioxidants-09-00919" ref-type="bibr">78</xref>]. From our results, we deduce that OmEO ameliorated only to some extent the fragmentation of DNA. Therefore, the anti-apoptotic properties of OmEO cannot be asserted with statistical significance. Hence, we further investigated the efficiency of OmEO in counteracting other biological processes, such as oxidative stress as well as cognitive function (<xref rid="antioxidants-09-00919-t001" ref-type="table">Table 1</xref>).</p></sec><sec id="sec3dot3dot3-antioxidants-09-00919"><title>3.3.3. Oxidative Stress</title><p>To test for oxidative stress responses, evaluation of lipid peroxidation and protein carbonylation was targeted. MDA, a secondary product of lipid peroxidation, is involved in multiple cellular processes and can promote intramolecular or intermolecular protein/DNA crosslinking, thus inducing profound alterations in the biochemical properties of a variety of biomolecules [<xref rid="B79-antioxidants-09-00919" ref-type="bibr">79</xref>]. Protein carbonylation, an irreversible oxidative damage, most often leads to a loss of protein function, but may also lead to gain of function. In both cases, even small changes in carbonylation may determine significant changes in cellular function, affecting major signaling pathways [<xref rid="B80-antioxidants-09-00919" ref-type="bibr">80</xref>,<xref rid="B81-antioxidants-09-00919" ref-type="bibr">81</xref>].</p><p>A&#x003b2;1-42 pretreated rats (II) presented a significantly higher levels of MDA and protein carbonyls (<italic>p</italic> = 0.0110 and <italic>p</italic> = 0.0283) (<xref ref-type="fig" rid="antioxidants-09-00919-f005">Figure 5</xref>A,B) compared to the sham-operated rats (I), revealing the potential of A&#x003b2;1-42 single administration to induce oxidative stress in entire organ. Next, it was observed that the inhaled OmEO proved to be very efficient in counteracting the induced oxidative stress, significantly reducing MDA levels in A&#x003b2;1-42 pretreated rats (<italic>p</italic> = 0.0023 for 1%OmEO and <italic>p</italic> = 0.0015 for 3%OmEO, respectively) (<xref ref-type="fig" rid="antioxidants-09-00919-f005">Figure 5</xref>A). The efficiency of OmEO in oxidative stress reduction was substantiated by the results obtained from analyzing carbonyl contents of proteins (<xref ref-type="fig" rid="antioxidants-09-00919-f005">Figure 5</xref>B), where only 1%OmEO (III) significantly decreased the protein carbonylation process within the brains of A&#x003b2;1-42 pretreated rats (II) (<italic>p</italic> = 0.0224).</p><p>Our results are in accordance with those from literature, where different lines of evidence suggest that A&#x003b2; acts as a pro-oxidant [<xref rid="B82-antioxidants-09-00919" ref-type="bibr">82</xref>], causing elevated levels of both MDA and protein carbonyls [<xref rid="B83-antioxidants-09-00919" ref-type="bibr">83</xref>]. Previous studies revealed the reducing oxidative stress proprieties of OmEO in vitro [<xref rid="B84-antioxidants-09-00919" ref-type="bibr">84</xref>] or in the context of nephrotoxicity, which was induced by different agents [<xref rid="B85-antioxidants-09-00919" ref-type="bibr">85</xref>,<xref rid="B86-antioxidants-09-00919" ref-type="bibr">86</xref>].</p><p>Of note, this in vivo study is the first which demonstrates the potential of OmEO to counteract oxidative stress in rat brain (hippocampus) which had been induced by administering a neurotoxic agent: A&#x003b2;1-42.</p></sec><sec id="sec3dot3dot4-antioxidants-09-00919"><title>3.3.4. Cognitive Function</title><p>RT-qPCR was used to analyze the expression of BDNF, and this widely distributed brain neurotrophin was selected to being assayed because of its involvement in critical regulatory roles of signaling pathways, which are involved in cognitive function-determining processes, such as developmental processes, neuroprotection, and synaptic plasticity [<xref rid="B87-antioxidants-09-00919" ref-type="bibr">87</xref>,<xref rid="B88-antioxidants-09-00919" ref-type="bibr">88</xref>] including short- and long-lasting synaptic interactions involved in the mechanism of memory and cognition.</p><p>When investigating brain-specific reactions onto OmEO-based aromatherapy, a significantly lower number of BDNF mRNA copies were determined in A&#x003b2;1-42 pretreated rats (II) compared to the sham-operated rats (I) (<italic>p</italic> &#x0003c; 0.0001) (<xref ref-type="fig" rid="antioxidants-09-00919-f006">Figure 6</xref>). In addition, it was observed that OmEO attenuated the damage induced by A&#x003b2;1-42 administration, as judged from a significant increase in BDNF expression being detected in the A&#x003b2;1-42 pretreated rats that inhaled the 1% concentration of the essential oil (III) (<italic>p</italic> = 0.0023). Yet, the 3% concentration of the OmEO (IV) was found to be somewhat less efficient in counteracting the harmful effects of A&#x003b2;1-42 (<italic>p</italic> = 0.08351) (<xref ref-type="fig" rid="antioxidants-09-00919-f006">Figure 6</xref>).</p><p>The impact of A&#x003b2; peptide on BDNF expression has been previously investigated by us [<xref rid="B38-antioxidants-09-00919" ref-type="bibr">38</xref>] and others [<xref rid="B89-antioxidants-09-00919" ref-type="bibr">89</xref>,<xref rid="B90-antioxidants-09-00919" ref-type="bibr">90</xref>] and, as also shown in this study, BDNF expression was found impaired upon intracerebroventricular A&#x003b2;1-42 delivery. More importantly, this study provides direct evidence of the beneficial effect of OmEO inhalation regarding BDNF expression in an AD-rat model.</p><p>Particularly, the positive effects of OmEO on cognitive function-associated processes encouraged behavioral tests with animals that had received aroma therapy after administration of A&#x003b2;1-42.</p></sec></sec><sec id="sec3dot4-antioxidants-09-00919"><title>3.4. Behavioral Tests</title><p>The Y-maze task was utilized to evaluate the short-term memory performance of rats that received different treatments, one-way ANOVA showing significant effects of these on spontaneous alternation behavior (F(3, 16) = 8.27, <italic>p</italic> = 0.0048). Single A&#x003b2;1-42 intracerebroventricular administration (II) caused a significant decrease in the spontaneous alternation behavior compared to the sham-operated control group (I) (<italic>p</italic> &#x0003c; 0.001) (<xref ref-type="fig" rid="antioxidants-09-00919-f007">Figure 7</xref>A). However, inhalation of the OmEO in both concentrations enhanced the performance of A&#x003b2;1-42 pretreated rats in the Y-maze test, significant improvements of the spontaneous alternation behavior being observed for the A&#x003b2;1-42 pretreated rats that inhaled 1%OmEO (III) (<italic>p</italic> = 0.0018), but not for those that inhaled 3%OmEO (IV) (<italic>p</italic> = 0.0950). The changes in the spontaneous alternation behavior cannot be attributed to the locomotor activity, as evidenced by the number of arm entries within the Y-maze task (<xref ref-type="fig" rid="antioxidants-09-00919-f007">Figure 7</xref>B).</p><p>In the radial arm maze task, two-way ANOVA analysis revealed major changes among the groups for both working memory performance (F(18, 112) = 43.98, <italic>p</italic> &#x0003c; 0.0001) (<xref ref-type="fig" rid="antioxidants-09-00919-f007">Figure 7</xref>C), as well as for reference memory performance (F(18, 112) = 9.29, <italic>p</italic> &#x0003c; 0.0001) (<xref ref-type="fig" rid="antioxidants-09-00919-f007">Figure 7</xref>D). As compared to the control group (I), the evaluation of the pretreated A&#x003b2;1-42 animals (II) was characterized by significant increments regarding the number of working memory errors (<italic>p</italic> &#x0003c; 0.0001) (<xref ref-type="fig" rid="antioxidants-09-00919-f007">Figure 7</xref>C), as well as the number of reference memory errors (<italic>p</italic> &#x0003c; 0.0001) (<xref ref-type="fig" rid="antioxidants-09-00919-f007">Figure 7</xref>D), proving that the single A&#x003b2;1-42 administration impaired the spatial memory. The inhaled OmEO in both concentrations (III and IV) determined a significant reduction of working memory errors in pretreated A&#x003b2;1-42 animals (<italic>p</italic> &#x0003c; 0.0001) (<xref ref-type="fig" rid="antioxidants-09-00919-f007">Figure 7</xref>C). On the other hand, reference memory acquisition was enhanced only in A&#x003b2;1-42 pretreated animals that inhaled 1%OmEO (III) (<italic>p</italic> = 0.0142) (<xref ref-type="fig" rid="antioxidants-09-00919-f007">Figure 7</xref>D). The inhalation of 3%OmEO (IV) did not improve the reference memory performance in A&#x003b2;1-42 pretreated animals (<italic>p</italic> = 0.9717) (<xref ref-type="fig" rid="antioxidants-09-00919-f007">Figure 7</xref>D).</p><p>These behavioral test results are in line with previous reports, which demonstrated the potential anti-AD effects of selected Lamiaceae plants [<xref rid="B91-antioxidants-09-00919" ref-type="bibr">91</xref>]. Altogether, our study provides evidence that OmEO ameliorates A&#x003b2;-induced perturbations, such as memory deficits, and offers insights into the cellular and molecular mechanisms involved in the protective effects of this essential oil against A&#x003b2;-induced cognitive dysfunctions.</p></sec></sec><sec sec-type="conclusions" id="sec4-antioxidants-09-00919"><title>4. Conclusions</title><p>In this study, we first confirmed the chemical composition of OmEO, which was applied for analyzing the proteomes of AD model rats, in search of differences that might be displayed on the molecular level. Through this approach, four biological processes&#x02014;neuroinflammation, apoptosis, oxidative stress, and cognitive functions modulated by neurotrophins&#x02014;were brought to attention as possibly affecting rat brain (hippocampi) performance as a likely consequence of OmEO administration. Whether or not the suggested biological processes were of significance was validated by testing matching targets, which are accepted representatives of the biological processes of interest. In this study, we found that OmEO promotes cognitive functions and reduces brain oxidative stress in A&#x003b2;1-42-treated rats. Finally, we correlated the cellular and molecular results with behavioral data, proving that OmEO enhances memory function in A&#x003b2;1-42-treated rats.</p></sec></body><back><app-group><app id="app1-antioxidants-09-00919"><title>Supplementary Materials</title><p>The following are available online at <uri xlink:href="https://www.mdpi.com/2076-3921/9/10/919/s1">https://www.mdpi.com/2076-3921/9/10/919/s1</uri>, Supplemental File 1. Excision of hippocampi and surrounding cerebral cortices for proteome analysis; Supplemental File 2 The phytochemical composition of OmEO; Supplemental File 3. Proteins were identified in the rat brain tissue containing hippocampi.</p><supplementary-material content-type="local-data" id="antioxidants-09-00919-s001"><media xlink:href="antioxidants-09-00919-s001.zip"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material></app></app-group><notes><title>Author Contributions</title><p>Conceptualization, P.A.P., M.O.G. and L.H.; methodology, P.A.P., D.L.G., O.C., M.R., S.M., M.O.G. and L.H.; software, P.A.P. and S.M.; investigation, P.A.P., D.L.G., O.C., M.R., S.M., M.O.G. and L.H.; resources, M.O.G. and L.H.; data curation, P.A.P., S.M., M.O.G.; writing&#x02014;original draft preparation, P.A.P., S.M. and M.O.G.; writing&#x02014;review and editing, P.A.P., M.O.G. and L.H.; supervision, M.O.G. and L.H. All authors have read and agreed to the published version of the manuscript.</p></notes><notes><title>Funding</title><p>This project is funded by the Ministry of Research and Innovation within Program 1&#x02014;Development of the national RD system, Subprogram 1.2&#x02014;Institutional Performance&#x02014;RDI excellence funding projects, Contract no. 34PFE/19.10.2018. The EU ERASMUS+ program is acknowledged for supporting teaching and research stays for M.O.G. and for P.A.P. in Romania and Germany, respectively (RO IASI 02). The WATERS Synapt G2S mass spectrometer was bought with an EU grant [EFRE-UHROM 9] made available to M.O.G.</p></notes><notes notes-type="COI-statement"><title>Conflicts of Interest</title><p>The authors declare no conflict of interest.</p></notes><ref-list><title>References</title><ref id="B1-antioxidants-09-00919"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cooke</surname><given-names>B.</given-names></name><name><surname>Ernst</surname><given-names>E.</given-names></name></person-group><article-title>Aromatherapy: A systematic review</article-title><source>Br. J. Gen. Pract.</source><year>2000</year><volume>50</volume><fpage>493</fpage><lpage>496</lpage><pub-id pub-id-type="pmid">10962794</pub-id></element-citation></ref><ref id="B2-antioxidants-09-00919"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>S&#x000e1;nchez-Vida&#x000f1;a</surname><given-names>D.I.</given-names></name><name><surname>Ngai</surname><given-names>S.P.-C.</given-names></name><name><surname>He</surname><given-names>W.</given-names></name><name><surname>Chow</surname><given-names>J.K.-W.</given-names></name><name><surname>Lau</surname><given-names>B.W.-M.</given-names></name><name><surname>Tsang</surname><given-names>H.W.H.</given-names></name></person-group><article-title>The Effectiveness of Aromatherapy for Depressive Symptoms: A Systematic Review</article-title><source>Evid. Based Complement. Altern. Med.</source><year>2017</year><volume>2017</volume><fpage>5869315</fpage><pub-id pub-id-type="doi">10.1155/2017/5869315</pub-id><?supplied-pmid 28133489?><pub-id pub-id-type="pmid">28133489</pub-id></element-citation></ref><ref id="B3-antioxidants-09-00919"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Swamy</surname><given-names>M.K.</given-names></name><name><surname>Akhtar</surname><given-names>M.S.</given-names></name><name><surname>Sinniah</surname><given-names>U.R.</given-names></name></person-group><article-title>Antimicrobial Properties of Plant Essential Oils against Human Pathogens and Their Mode of Action: An Updated Review</article-title><source>Evid. Based Complement. Altern. Med.</source><year>2016</year><volume>2016</volume><fpage>3012462</fpage><pub-id pub-id-type="doi">10.1155/2016/3012462</pub-id><?supplied-pmid 28090211?><pub-id pub-id-type="pmid">28090211</pub-id></element-citation></ref><ref id="B4-antioxidants-09-00919"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Amorati</surname><given-names>R.</given-names></name><name><surname>Foti</surname><given-names>M.C.</given-names></name><name><surname>Valgimigli</surname><given-names>L.</given-names></name></person-group><article-title>Antioxidant Activity of Essential Oils</article-title><source>J. Agric. Food Chem.</source><year>2013</year><volume>61</volume><fpage>10835</fpage><lpage>10847</lpage><pub-id pub-id-type="doi">10.1021/jf403496k</pub-id><pub-id pub-id-type="pmid">24156356</pub-id></element-citation></ref><ref id="B5-antioxidants-09-00919"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dhany</surname><given-names>A.L.</given-names></name><name><surname>Mitchell</surname><given-names>T.</given-names></name><name><surname>Foy</surname><given-names>C.</given-names></name></person-group><article-title>Aromatherapy and Massage Intrapartum Service Impact on Use of Analgesia and Anesthesia in Women in Labor: A Retrospective Case Note Analysis</article-title><source>J. Altern. Complement. Med.</source><year>2012</year><volume>18</volume><fpage>932</fpage><lpage>938</lpage><pub-id pub-id-type="doi">10.1089/acm.2011.0254</pub-id><pub-id pub-id-type="pmid">22897435</pub-id></element-citation></ref><ref id="B6-antioxidants-09-00919"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jun</surname><given-names>Y.S.</given-names></name><name><surname>Kang</surname><given-names>P.</given-names></name><name><surname>Min</surname><given-names>S.S.</given-names></name><name><surname>Lee</surname><given-names>J.-M.</given-names></name><name><surname>Kim</surname><given-names>H.-K.</given-names></name><name><surname>Seol</surname><given-names>G.H.</given-names></name></person-group><article-title>Effect of Eucalyptus Oil Inhalation on Pain and Inflammatory Responses after Total Knee Replacement: A Randomized Clinical Trial</article-title><source>Evid. Based Complement. Altern. Med.</source><year>2013</year><volume>2013</volume><fpage>502727</fpage><pub-id pub-id-type="doi">10.1155/2013/502727</pub-id><?supplied-pmid 23853660?><pub-id pub-id-type="pmid">23853660</pub-id></element-citation></ref><ref id="B7-antioxidants-09-00919"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ayan</surname><given-names>M.</given-names></name><name><surname>Ta&#x0015f;</surname><given-names>U.</given-names></name><name><surname>Sogut</surname><given-names>E.</given-names></name><name><surname>Suren</surname><given-names>M.</given-names></name><name><surname>Gurbuzler</surname><given-names>L.</given-names></name><name><surname>Koyuncu</surname><given-names>F.</given-names></name></person-group><article-title>Investigating the Effect of Aromatherapy in Patients with Renal Colic</article-title><source>J. Altern. Complement. Med.</source><year>2013</year><volume>19</volume><fpage>329</fpage><lpage>333</lpage><pub-id pub-id-type="doi">10.1089/acm.2011.0941</pub-id><pub-id pub-id-type="pmid">23072267</pub-id></element-citation></ref><ref id="B8-antioxidants-09-00919"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Perry</surname><given-names>N.</given-names></name><name><surname>Perry</surname><given-names>E.</given-names></name></person-group><article-title>Aromatherapy in the Management of Psychiatric Disorders</article-title><source>CNS Drugs</source><year>2006</year><volume>20</volume><fpage>257</fpage><lpage>280</lpage><pub-id pub-id-type="doi">10.2165/00023210-200620040-00001</pub-id><?supplied-pmid 16599645?><pub-id pub-id-type="pmid">16599645</pub-id></element-citation></ref><ref id="B9-antioxidants-09-00919"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ni</surname><given-names>C.-H.</given-names></name><name><surname>Hou</surname><given-names>W.-H.</given-names></name><name><surname>Kao</surname><given-names>C.-C.</given-names></name><name><surname>Chang</surname><given-names>M.-L.</given-names></name><name><surname>Yu</surname><given-names>L.-F.</given-names></name><name><surname>Wu</surname><given-names>C.-C.</given-names></name><name><surname>Chen</surname><given-names>C.</given-names></name></person-group><article-title>The Anxiolytic Effect of Aromatherapy on Patients Awaiting Ambulatory Surgery: A Randomized Controlled Trial</article-title><source>Evid. Based Complement. Altern. Med.</source><year>2013</year><volume>2013</volume><fpage>927419</fpage><pub-id pub-id-type="doi">10.1155/2013/927419</pub-id></element-citation></ref><ref id="B10-antioxidants-09-00919"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Conrad</surname><given-names>P.</given-names></name><name><surname>Adams</surname><given-names>C.</given-names></name></person-group><article-title>The effects of clinical aromatherapy for anxiety and depression in the high risk postpartum woman&#x02014;A pilot study</article-title><source>Complement. Ther. Clin. Pract.</source><year>2012</year><volume>18</volume><fpage>164</fpage><lpage>168</lpage><pub-id pub-id-type="doi">10.1016/j.ctcp.2012.05.002</pub-id><pub-id pub-id-type="pmid">22789792</pub-id></element-citation></ref><ref id="B11-antioxidants-09-00919"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bina</surname><given-names>F.</given-names></name><name><surname>Rahimi</surname><given-names>R.</given-names></name></person-group><article-title>Sweet Marjoram: A Review of Ethnopharmacology, Phytochemistry, and Biological Activities</article-title><source>J. Evid. Based Integr. Med.</source><year>2016</year><volume>22</volume><fpage>175</fpage><lpage>185</lpage><pub-id pub-id-type="doi">10.1177/2156587216650793</pub-id><?supplied-pmid 27231340?><pub-id pub-id-type="pmid">27231340</pub-id></element-citation></ref><ref id="B12-antioxidants-09-00919"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Erenler</surname><given-names>R.</given-names></name><name><surname>Sen</surname><given-names>O.</given-names></name><name><surname>Ak&#x0015f;it</surname><given-names>H.</given-names></name><name><surname>Demirta&#x0015f;</surname><given-names>I.</given-names></name><name><surname>Ya&#x0011f;l&#x00131;o&#x0011f;lu</surname><given-names>A.&#x0015e;.</given-names></name><name><surname>Elmastas</surname><given-names>M.</given-names></name><name><surname>Telci</surname><given-names>I.</given-names></name><name><surname>Yaglioglu</surname><given-names>A.S.</given-names></name></person-group><article-title>Isolation and identification of chemical constituents from Origanum majorana and investigation of antiproliferative and antioxidant activities</article-title><source>J. Sci. Food Agric.</source><year>2015</year><volume>96</volume><fpage>822</fpage><lpage>836</lpage><pub-id pub-id-type="doi">10.1002/jsfa.7155</pub-id><?supplied-pmid 25721137?><pub-id pub-id-type="pmid">25721137</pub-id></element-citation></ref><ref id="B13-antioxidants-09-00919"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Della Pepa</surname><given-names>T.</given-names></name><name><surname>Elshafie</surname><given-names>H.S.</given-names></name><name><surname>Capasso</surname><given-names>R.</given-names></name><name><surname>De Feo</surname><given-names>V.</given-names></name><name><surname>Camele</surname><given-names>I.</given-names></name><name><surname>Nazzaro</surname><given-names>F.</given-names></name><name><surname>Scognamiglio</surname><given-names>M.</given-names></name><name><surname>Caputo</surname><given-names>L.</given-names></name></person-group><article-title>Antimicrobial and Phytotoxic Activity of <italic>Origanum heracleoticum</italic> and <italic>O. majorana</italic> Essential Oils Growing in Cilento (Southern Italy)</article-title><source>Molecules</source><year>2019</year><volume>24</volume><elocation-id>2576</elocation-id><pub-id pub-id-type="doi">10.3390/molecules24142576</pub-id><?supplied-pmid 31315175?><pub-id pub-id-type="pmid">31315175</pub-id></element-citation></ref><ref id="B14-antioxidants-09-00919"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marques</surname><given-names>J.D.L.</given-names></name><name><surname>Volc&#x000e3;o</surname><given-names>L.M.</given-names></name><name><surname>Funck</surname><given-names>G.D.</given-names></name><name><surname>Kroning</surname><given-names>I.S.</given-names></name><name><surname>Da Silva</surname><given-names>W.P.</given-names></name><name><surname>Fiorentini</surname><given-names>&#x000c2;.M.</given-names></name><name><surname>Ribeiro</surname><given-names>G.A.</given-names></name></person-group><article-title>Antimicrobial activity of essential oils of <italic>Origanum vulgare</italic> L. and <italic>Origanum majorana</italic> L. against Staphylococcus aureus isolated from poultry meat</article-title><source>Ind. Crop. Prod.</source><year>2015</year><volume>77</volume><fpage>444</fpage><lpage>450</lpage><pub-id pub-id-type="doi">10.1016/j.indcrop.2015.09.013</pub-id></element-citation></ref><ref id="B15-antioxidants-09-00919"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mossa</surname><given-names>A.-T.H.</given-names></name><name><surname>Refaie</surname><given-names>A.</given-names></name><name><surname>Ramadan</surname><given-names>A.</given-names></name><name><surname>Bouajila</surname><given-names>J.</given-names></name></person-group><article-title>Amelioration of Prallethrin-Induced Oxidative Stress and Hepatotoxicity in Rat by the Administration of <italic>Origanum majorana</italic> Essential Oil</article-title><source>BioMed Res. Int.</source><year>2013</year><volume>2013</volume><fpage>859085</fpage><pub-id pub-id-type="doi">10.1155/2013/859085</pub-id><pub-id pub-id-type="pmid">24381944</pub-id></element-citation></ref><ref id="B16-antioxidants-09-00919"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mossa</surname><given-names>A.-T.H.</given-names></name><name><surname>Nawwar</surname><given-names>G.A.M.</given-names></name></person-group><article-title>Free radical scavenging and antiacetylcholinesterase activities of <italic>Origanum majorana</italic> L. essential oil</article-title><source>Hum. Exp. Toxicol.</source><year>2011</year><volume>30</volume><fpage>1501</fpage><lpage>1513</lpage><pub-id pub-id-type="doi">10.1177/0960327110391686</pub-id><pub-id pub-id-type="pmid">21239482</pub-id></element-citation></ref><ref id="B17-antioxidants-09-00919"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Al Dhaheri</surname><given-names>Y.</given-names></name><name><surname>Attoub</surname><given-names>S.</given-names></name><name><surname>Arafat</surname><given-names>K.</given-names></name><name><surname>AbuQamar</surname><given-names>S.F.</given-names></name><name><surname>Viallet</surname><given-names>J.</given-names></name><name><surname>Saleh</surname><given-names>A.</given-names></name><name><surname>Al Agha</surname><given-names>H.</given-names></name><name><surname>Eid</surname><given-names>A.H.</given-names></name><name><surname>Iratni</surname><given-names>R.</given-names></name></person-group><article-title>Anti-Metastatic and Anti-Tumor Growth Effects of <italic>Origanum majorana</italic> on Highly Metastatic Human Breast Cancer Cells: Inhibition of NF&#x003ba;B Signaling and Reduction of Nitric Oxide Production</article-title><source>PLoS ONE</source><year>2013</year><volume>8</volume><elocation-id>e68808</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0068808</pub-id><pub-id pub-id-type="pmid">23874773</pub-id></element-citation></ref><ref id="B18-antioxidants-09-00919"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abbasi-Maleki</surname><given-names>S.</given-names></name><name><surname>Kadkhoda</surname><given-names>Z.</given-names></name><name><surname>Taghizad-Farid</surname><given-names>R.</given-names></name></person-group><article-title>The antidepressant-like effects of Origanum majorana essential oil on mice through monoaminergic modulation using the forced swimming test</article-title><source>J. Tradit. Complement. Med.</source><year>2019</year><volume>10</volume><fpage>327</fpage><lpage>335</lpage><pub-id pub-id-type="doi">10.1016/j.jtcme.2019.01.003</pub-id><pub-id pub-id-type="pmid">32695649</pub-id></element-citation></ref><ref id="B19-antioxidants-09-00919"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Merino</surname><given-names>J.J.</given-names></name><name><surname>Parmigiani-Izquierdo</surname><given-names>J.M.</given-names></name><name><surname>L&#x000f3;pez-Oliva</surname><given-names>M.E.</given-names></name><name><surname>Caba&#x000f1;a-Mu&#x000f1;oz</surname><given-names>M.E.</given-names></name></person-group><article-title>Origanum majorana Essential Oil Inhalation during Neurofeedback Training Reduces Saliva Myeloperoxidase Activity at Session-1 in Bruxistic Patients</article-title><source>J. Clin. Med.</source><year>2019</year><volume>8</volume><elocation-id>158</elocation-id><pub-id pub-id-type="doi">10.3390/jcm8020158</pub-id></element-citation></ref><ref id="B20-antioxidants-09-00919"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jungbauer</surname><given-names>A.</given-names></name><name><surname>Medjakovic</surname><given-names>S.</given-names></name></person-group><article-title>Anti-inflammatory properties of culinary herbs and spices that ameliorate the effects of metabolic syndrome</article-title><source>Maturitas</source><year>2012</year><volume>71</volume><fpage>227</fpage><lpage>239</lpage><pub-id pub-id-type="doi">10.1016/j.maturitas.2011.12.009</pub-id><pub-id pub-id-type="pmid">22226987</pub-id></element-citation></ref><ref id="B21-antioxidants-09-00919"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arranz</surname><given-names>E.</given-names></name><name><surname>Jaime</surname><given-names>L.</given-names></name><name><surname>L&#x000f3;pez de las Hazas</surname><given-names>M.C.</given-names></name><name><surname>Reglero</surname><given-names>G.</given-names></name><name><surname>Santoyo</surname><given-names>S.</given-names></name></person-group><article-title>Supercritical fluid extraction as an alternative process to obtain essential oils with anti-inflammatory properties from marjoram and sweet basil</article-title><source>Ind. Crop. Prod.</source><year>2015</year><volume>67</volume><fpage>121</fpage><lpage>129</lpage><pub-id pub-id-type="doi">10.1016/j.indcrop.2015.01.012</pub-id></element-citation></ref><ref id="B22-antioxidants-09-00919"><label>22.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Cardenas-Aguayo</surname><given-names>M.D.C.</given-names></name><name><surname>Silva-Lucero</surname><given-names>M.D.C.</given-names></name><name><surname>Cortes-Ortiz</surname><given-names>M.</given-names></name><name><surname>Jimnez-Ramos</surname><given-names>B.</given-names></name><name><surname>Gmez-Virgilio</surname><given-names>L.</given-names></name><name><surname>Ramrez-Rodrguez</surname><given-names>G.</given-names></name><name><surname>Arroyo</surname><given-names>E.V.</given-names></name><name><surname>Fiorentino-Prez</surname><given-names>R.</given-names></name><name><surname>Garca</surname><given-names>U.</given-names></name><name><surname>Luna-Muoz</surname><given-names>J.</given-names></name><etal/></person-group><article-title>Physiological Role of Amyloid Beta in Neural Cells: The Cellular Trophic Activity</article-title><source>Neurochemistry</source><person-group person-group-type="editor"><name><surname>Heinbockel</surname><given-names>T.</given-names></name></person-group><publisher-name>IntechOpen</publisher-name><publisher-loc>London, UK</publisher-loc><year>2014</year><fpage>257</fpage><lpage>281</lpage><pub-id pub-id-type="doi">10.5772/57398</pub-id></element-citation></ref><ref id="B23-antioxidants-09-00919"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mcintee</surname><given-names>F.L.</given-names></name><name><surname>Giannoni</surname><given-names>P.</given-names></name><name><surname>Blais</surname><given-names>S.</given-names></name><name><surname>Sommer</surname><given-names>G.</given-names></name><name><surname>Neubert</surname><given-names>T.A.</given-names></name><name><surname>Rostagno</surname><given-names>A.</given-names></name><name><surname>Ghiso</surname><given-names>J.</given-names></name></person-group><article-title>In vivo Differential Brain Clearance and Catabolism of Monomeric and Oligomeric Alzheimer&#x02019;s A&#x003b2; protein</article-title><source>Front. Aging Neurosci.</source><year>2016</year><volume>8</volume><fpage>223</fpage><pub-id pub-id-type="doi">10.3389/fnagi.2016.00223</pub-id><?supplied-pmid 27729857?><pub-id pub-id-type="pmid">27729857</pub-id></element-citation></ref><ref id="B24-antioxidants-09-00919"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>C.</given-names></name><name><surname>Browne</surname><given-names>A.</given-names></name><name><surname>DiVito</surname><given-names>J.R.</given-names></name><name><surname>Stevenson</surname><given-names>J.A.</given-names></name><name><surname>Romano</surname><given-names>D.</given-names></name><name><surname>Dong</surname><given-names>Y.</given-names></name><name><surname>Xie</surname><given-names>Z.</given-names></name><name><surname>Tanzi</surname><given-names>R.E.</given-names></name></person-group><article-title>Amyloid-&#x003b2; Production via Cleavage of Amyloid-&#x003b2; Protein Precursor Is Modulated by Cell Density</article-title><source>J. Alzheimer&#x02019;s Dis.</source><year>2010</year><volume>22</volume><fpage>683</fpage><lpage>694</lpage><pub-id pub-id-type="doi">10.3233/JAD-2010-100816</pub-id><pub-id pub-id-type="pmid">20847415</pub-id></element-citation></ref><ref id="B25-antioxidants-09-00919"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morgese</surname><given-names>M.G.</given-names></name><name><surname>Colaianna</surname><given-names>M.</given-names></name><name><surname>Mhillaj</surname><given-names>E.</given-names></name><name><surname>Zotti</surname><given-names>M.</given-names></name><name><surname>Schiavone</surname><given-names>S.</given-names></name><name><surname>D&#x02019;Antonio</surname><given-names>P.</given-names></name><name><surname>Harkin</surname><given-names>A.</given-names></name><name><surname>Gigliucci</surname><given-names>V.</given-names></name><name><surname>Campolongo</surname><given-names>P.</given-names></name><name><surname>Trezza</surname><given-names>V.</given-names></name><etal/></person-group><article-title>Soluble beta amyloid evokes alteration in brain norepinephrine levels: Role of nitric oxide and interleukin-1</article-title><source>Front. Mol. Neurosci.</source><year>2015</year><volume>9</volume><fpage>428</fpage><pub-id pub-id-type="doi">10.3389/fnins.2015.00428</pub-id></element-citation></ref><ref id="B26-antioxidants-09-00919"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mucke</surname><given-names>L.</given-names></name><name><surname>Selkoe</surname><given-names>D.J.</given-names></name></person-group><article-title>Neurotoxicity of Amyloid &#x003b2;-Protein: Synaptic and Network Dysfunction</article-title><source>Cold Spring Harb. Perspect. Med.</source><year>2012</year><volume>2</volume><fpage>a006338</fpage><pub-id pub-id-type="doi">10.1101/cshperspect.a006338</pub-id><?supplied-pmid 22762015?><pub-id pub-id-type="pmid">22762015</pub-id></element-citation></ref><ref id="B27-antioxidants-09-00919"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Puzzo</surname><given-names>D.</given-names></name><name><surname>Privitera</surname><given-names>L.</given-names></name><name><surname>Leznik</surname><given-names>E.</given-names></name><name><surname>F&#x000e0;</surname><given-names>M.</given-names></name><name><surname>Staniszewski</surname><given-names>A.</given-names></name><name><surname>Palmeri</surname><given-names>A.</given-names></name><name><surname>Arancio</surname><given-names>O.</given-names></name></person-group><article-title>Picomolar amyloid-beta positively modulates synaptic plasticity and memory in hippocampus</article-title><source>J. Neurosci.</source><year>2008</year><volume>28</volume><fpage>14537</fpage><lpage>14545</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.2692-08.2008</pub-id><pub-id pub-id-type="pmid">19118188</pub-id></element-citation></ref><ref id="B28-antioxidants-09-00919"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carrillo-Mora</surname><given-names>P.</given-names></name><name><surname>Luna</surname><given-names>R.</given-names></name><name><surname>Col&#x000ed;n-Barenque</surname><given-names>L.</given-names></name></person-group><article-title>Amyloid Beta: Multiple Mechanisms of Toxicity and Only Some Protective Effects?</article-title><source>Oxidative Med. Cell. Longev.</source><year>2014</year><volume>2014</volume><fpage>795375</fpage><pub-id pub-id-type="doi">10.1155/2014/795375</pub-id></element-citation></ref><ref id="B29-antioxidants-09-00919"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Poon</surname><given-names>W.W.</given-names></name><name><surname>Carlos</surname><given-names>A.J.</given-names></name><name><surname>Aguilar</surname><given-names>B.L.</given-names></name><name><surname>Berchtold</surname><given-names>N.C.</given-names></name><name><surname>Kawano</surname><given-names>C.K.</given-names></name><name><surname>Zograbyan</surname><given-names>V.</given-names></name><name><surname>Yaopruke</surname><given-names>T.</given-names></name><name><surname>Shelanski</surname><given-names>M.</given-names></name><name><surname>Cotman</surname><given-names>C.W.</given-names></name></person-group><article-title>&#x003b2;-Amyloid (A&#x003b2;) Oligomers Impair Brain-derived Neurotrophic Factor Retrograde Trafficking by Down-regulating Ubiquitin C-terminal Hydrolase, UCH-L1</article-title><source>J. Boil. Chem.</source><year>2013</year><volume>288</volume><fpage>16937</fpage><lpage>16948</lpage><pub-id pub-id-type="doi">10.1074/jbc.M113.463711</pub-id></element-citation></ref><ref id="B30-antioxidants-09-00919"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cheignon</surname><given-names>C.</given-names></name><name><surname>Tomas</surname><given-names>M.</given-names></name><name><surname>Bonnefont-Rousselot</surname><given-names>D.</given-names></name><name><surname>Faller</surname><given-names>P.</given-names></name><name><surname>Hureau</surname><given-names>C.</given-names></name><name><surname>Collin</surname><given-names>F.</given-names></name></person-group><article-title>Oxidative stress and the amyloid beta peptide in Alzheimer&#x02019;s disease</article-title><source>Redox Boil.</source><year>2018</year><volume>14</volume><fpage>450</fpage><lpage>464</lpage><pub-id pub-id-type="doi">10.1016/j.redox.2017.10.014</pub-id></element-citation></ref><ref id="B31-antioxidants-09-00919"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gupta</surname><given-names>P.</given-names></name><name><surname>Sil</surname><given-names>S.</given-names></name><name><surname>Ghosh</surname><given-names>R.</given-names></name><name><surname>Ghosh</surname><given-names>A.</given-names></name><name><surname>Ghosh</surname><given-names>T.</given-names></name></person-group><article-title>Intracerebroventricular A&#x003b2;-Induced Neuroinflammation Alters Peripheral Immune Responses in Rats</article-title><source>J. Mol. Neurosci.</source><year>2018</year><volume>66</volume><fpage>572</fpage><lpage>586</lpage><pub-id pub-id-type="doi">10.1007/s12031-018-1189-9</pub-id><pub-id pub-id-type="pmid">30377887</pub-id></element-citation></ref><ref id="B32-antioxidants-09-00919"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carret-Rebillat</surname><given-names>A.-S.</given-names></name><name><surname>Pace</surname><given-names>C.</given-names></name><name><surname>Gourmaud</surname><given-names>S.</given-names></name><name><surname>Ravasi</surname><given-names>L.</given-names></name><name><surname>Montagne-Stora</surname><given-names>S.</given-names></name><name><surname>Longueville</surname><given-names>S.</given-names></name><name><surname>Tible</surname><given-names>M.</given-names></name><name><surname>Sudol</surname><given-names>E.</given-names></name><name><surname>Chang</surname><given-names>R.C.-C.</given-names></name><name><surname>Paquet</surname><given-names>C.</given-names></name><etal/></person-group><article-title>Neuroinflammation and A&#x003b2; Accumulation Linked To Systemic Inflammation Are Decreased By Genetic PKR Down-Regulation</article-title><source>Sci. Rep.</source><year>2015</year><volume>5</volume><fpage>8489</fpage><pub-id pub-id-type="doi">10.1038/srep08489</pub-id><?supplied-pmid 25687824?><pub-id pub-id-type="pmid">25687824</pub-id></element-citation></ref><ref id="B33-antioxidants-09-00919"><label>33.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Adams</surname><given-names>R.P.</given-names></name></person-group><source>Identification of Essential Oil Components by Gas Chromatography/Mass Spectrometry</source><edition>4th ed.</edition><publisher-name>Allured Pub Corp</publisher-name><publisher-loc>Carol Stream, IL, USA</publisher-loc><year>2007</year></element-citation></ref><ref id="B34-antioxidants-09-00919"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Postu</surname><given-names>P.A.</given-names></name><name><surname>Sadiki</surname><given-names>F.Z.</given-names></name><name><surname>El Idrissi</surname><given-names>M.</given-names></name><name><surname>Cioanca</surname><given-names>O.</given-names></name><name><surname>Trifan</surname><given-names>A.</given-names></name><name><surname>Hancianu</surname><given-names>M.</given-names></name><name><surname>Hritcu</surname><given-names>L.</given-names></name></person-group><article-title><italic>Pinus halepensis</italic> essential oil attenuates the toxic Alzheimer&#x02019;s amyloid beta (1-42)-induced memory impairment and oxidative stress in the rat hippocampus</article-title><source>Biomed. Pharmacother.</source><year>2019</year><volume>112</volume><fpage>108673</fpage><pub-id pub-id-type="doi">10.1016/j.biopha.2019.108673</pub-id><?supplied-pmid 30784941?><pub-id pub-id-type="pmid">30784941</pub-id></element-citation></ref><ref id="B35-antioxidants-09-00919"><label>35.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Paxinos</surname><given-names>G.</given-names></name><name><surname>Watson</surname><given-names>C.</given-names></name></person-group><source>The Rat Brain in Stereotaxiccoordinates</source><edition>6th ed.</edition><publisher-name>Academic Press</publisher-name><publisher-loc>San Diego, CA, USA</publisher-loc><year>2005</year></element-citation></ref><ref id="B36-antioxidants-09-00919"><label>36.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Bate</surname><given-names>S.T.</given-names></name><name><surname>Clark</surname><given-names>R.A.</given-names></name></person-group><source>The Design and Statistical Analysis of Animal Experiments</source><publisher-name>Cambridge University Press</publisher-name><publisher-loc>Cambridge, UK</publisher-loc><year>2014</year></element-citation></ref><ref id="B37-antioxidants-09-00919"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname><given-names>P.</given-names></name><name><surname>Krohn</surname><given-names>R.</given-names></name><name><surname>Hermanson</surname><given-names>G.</given-names></name><name><surname>Mallia</surname><given-names>A.</given-names></name><name><surname>Gartner</surname><given-names>F.</given-names></name><name><surname>Provenzano</surname><given-names>M.</given-names></name><name><surname>Fujimoto</surname><given-names>E.</given-names></name><name><surname>Goeke</surname><given-names>N.</given-names></name><name><surname>Olson</surname><given-names>B.</given-names></name><name><surname>Klenk</surname><given-names>D.</given-names></name></person-group><article-title>Measurement of protein using bicinchoninic acid</article-title><source>Anal. Biochem.</source><year>1985</year><volume>150</volume><fpage>76</fpage><lpage>85</lpage><pub-id pub-id-type="doi">10.1016/0003-2697(85)90442-7</pub-id><pub-id pub-id-type="pmid">3843705</pub-id></element-citation></ref><ref id="B38-antioxidants-09-00919"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Postu</surname><given-names>P.A.</given-names></name><name><surname>Noumedem</surname><given-names>J.A.</given-names></name><name><surname>Cioanca</surname><given-names>O.</given-names></name><name><surname>Hancianu</surname><given-names>M.</given-names></name><name><surname>Mihasan</surname><given-names>M.</given-names></name><name><surname>Ciorpac</surname><given-names>M.</given-names></name><name><surname>Gorgan</surname><given-names>L.D.</given-names></name><name><surname>Petre</surname><given-names>B.A.</given-names></name><name><surname>Hritcu</surname><given-names>L.</given-names></name></person-group><article-title><italic>Lactuca capensis</italic> reverses memory deficits in A&#x003b2;1-42-induced an animal model of Alzheimer&#x02019;s disease</article-title><source>J. Cell. Mol. Med.</source><year>2017</year><volume>22</volume><fpage>111</fpage><lpage>122</lpage><pub-id pub-id-type="doi">10.1111/jcmm.13299</pub-id><?supplied-pmid 28816008?><pub-id pub-id-type="pmid">28816008</pub-id></element-citation></ref><ref id="B39-antioxidants-09-00919"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bantscheff</surname><given-names>M.</given-names></name><name><surname>Ringel</surname><given-names>B.</given-names></name><name><surname>M&#x000e1;di</surname><given-names>A.</given-names></name><name><surname>Schnabel</surname><given-names>R.</given-names></name><name><surname>Glocker</surname><given-names>M.O.</given-names></name><name><surname>Thiesen</surname><given-names>H.-J.</given-names></name></person-group><article-title>Differential proteome analysis and mass spectrometric characterization of germ line development-related proteins of <italic>Caenorhabditis elegans</italic></article-title><source>Proteomics</source><year>2004</year><volume>4</volume><fpage>2283</fpage><lpage>2295</lpage><pub-id pub-id-type="doi">10.1002/pmic.200400807</pub-id><?supplied-pmid 15274122?><pub-id pub-id-type="pmid">15274122</pub-id></element-citation></ref><ref id="B40-antioxidants-09-00919"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Just</surname><given-names>T.</given-names></name><name><surname>Gafumbegete</surname><given-names>E.</given-names></name><name><surname>Gramberg</surname><given-names>J.</given-names></name><name><surname>Pr&#x000fc;fer</surname><given-names>I.</given-names></name><name><surname>Mikkat</surname><given-names>S.</given-names></name><name><surname>Ringel</surname><given-names>B.</given-names></name><name><surname>Pau</surname><given-names>H.W.</given-names></name><name><surname>Glocker</surname><given-names>M.O.</given-names></name></person-group><article-title>Differential proteome analysis of tonsils from children with chronic tonsillitis or with hyperplasia reveals disease-associated protein expression differences</article-title><source>Anal. Bioanal. Chem.</source><year>2006</year><volume>384</volume><fpage>1134</fpage><lpage>1144</lpage><pub-id pub-id-type="doi">10.1007/s00216-005-0288-y</pub-id><pub-id pub-id-type="pmid">16479370</pub-id></element-citation></ref><ref id="B41-antioxidants-09-00919"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>R&#x000f6;wer</surname><given-names>C.</given-names></name><name><surname>George</surname><given-names>C.</given-names></name><name><surname>Reimer</surname><given-names>T.</given-names></name><name><surname>Stengel</surname><given-names>B.</given-names></name><name><surname>Radtke</surname><given-names>A.</given-names></name><name><surname>Gerber</surname><given-names>B.</given-names></name><name><surname>Glocker</surname><given-names>M.O.</given-names></name></person-group><article-title>Distinct Ezrin Truncations Differentiate Metastases in Sentinel Lymph Nodes from Unaffected Lymph Node Tissues, from Primary Breast Tumors, and from Healthy Glandular Breast Tissues</article-title><source>Transl. Oncol.</source><year>2017</year><volume>11</volume><fpage>1</fpage><lpage>10</lpage><pub-id pub-id-type="doi">10.1016/j.tranon.2017.10.004</pub-id><pub-id pub-id-type="pmid">29132012</pub-id></element-citation></ref><ref id="B42-antioxidants-09-00919"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Masuda</surname><given-names>T.</given-names></name><name><surname>Tomita</surname><given-names>M.</given-names></name><name><surname>Ishihama</surname><given-names>Y.</given-names></name></person-group><article-title>Phase Transfer Surfactant-Aided Trypsin Digestion for Membrane Proteome Analysis</article-title><source>J. Proteome Res.</source><year>2008</year><volume>7</volume><fpage>731</fpage><lpage>740</lpage><pub-id pub-id-type="doi">10.1021/pr700658q</pub-id><pub-id pub-id-type="pmid">18183947</pub-id></element-citation></ref><ref id="B43-antioxidants-09-00919"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pappesch</surname><given-names>R.</given-names></name><name><surname>Warnke</surname><given-names>P.</given-names></name><name><surname>Mikkat</surname><given-names>S.</given-names></name><name><surname>Normann</surname><given-names>J.</given-names></name><name><surname>Wisniewska-Kucper</surname><given-names>A.</given-names></name><name><surname>Huschka</surname><given-names>F.</given-names></name><name><surname>Wittmann</surname><given-names>M.</given-names></name><name><surname>Khani</surname><given-names>A.</given-names></name><name><surname>Schwengers</surname><given-names>O.</given-names></name><name><surname>Oehmcke-Hecht</surname><given-names>S.</given-names></name><etal/></person-group><article-title>The Regulatory Small RNA MarS Supports Virulence of Streptococcus pyogenes</article-title><source>Sci. Rep.</source><year>2017</year><volume>7</volume><fpage>12241</fpage><pub-id pub-id-type="doi">10.1038/s41598-017-12507-z</pub-id><pub-id pub-id-type="pmid">28947755</pub-id></element-citation></ref><ref id="B44-antioxidants-09-00919"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yefremova</surname><given-names>Y.</given-names></name><name><surname>Opuni</surname><given-names>K.F.M.</given-names></name><name><surname>Danquah</surname><given-names>B.D.</given-names></name><name><surname>Thiesen</surname><given-names>H.-J.</given-names></name><name><surname>Glocker</surname><given-names>M.O.</given-names></name></person-group><article-title>Intact Transition Epitope Mapping (ITEM)</article-title><source>J. Am. Soc. Mass Spectrom.</source><year>2017</year><volume>28</volume><fpage>1612</fpage><lpage>1622</lpage><pub-id pub-id-type="doi">10.1007/s13361-017-1654-7</pub-id><pub-id pub-id-type="pmid">28616748</pub-id></element-citation></ref><ref id="B45-antioxidants-09-00919"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>W&#x000f6;lter</surname><given-names>M.</given-names></name><name><surname>Okai</surname><given-names>C.A.</given-names></name><name><surname>Smith</surname><given-names>D.S.</given-names></name><name><surname>Ru&#x000df;</surname><given-names>M.</given-names></name><name><surname>Rath</surname><given-names>W.</given-names></name><name><surname>Pecks</surname><given-names>U.</given-names></name><name><surname>Borchers</surname><given-names>C.H.</given-names></name><name><surname>Glocker</surname><given-names>M.O.</given-names></name></person-group><article-title>Maternal Apolipoprotein B100 Serum Levels are Diminished in Pregnancies with Intrauterine Growth Restriction and Differentiate from Controls</article-title><source>Proteom. Clin. Appl.</source><year>2018</year><volume>12</volume><pub-id pub-id-type="doi">10.1002/prca.201800017</pub-id><?supplied-pmid 29956482?><pub-id pub-id-type="pmid">29956482</pub-id></element-citation></ref><ref id="B46-antioxidants-09-00919"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kumar</surname><given-names>V.V.</given-names></name><name><surname>James</surname><given-names>B.L.</given-names></name><name><surname>Ru&#x000df;</surname><given-names>M.</given-names></name><name><surname>Mikkat</surname><given-names>S.</given-names></name><name><surname>Suresh</surname><given-names>A.</given-names></name><name><surname>K&#x000e4;mmerer</surname><given-names>P.W.</given-names></name><name><surname>Glocker</surname><given-names>M.O.</given-names></name></person-group><article-title>Proteome analysis reveals that de novo regenerated mucosa over fibula flap-reconstructed mandibles resembles mature keratinized oral mucosa</article-title><source>Oral Oncol.</source><year>2018</year><volume>78</volume><fpage>207</fpage><lpage>215</lpage><pub-id pub-id-type="doi">10.1016/j.oraloncology.2018.01.017</pub-id><?supplied-pmid 29496052?><pub-id pub-id-type="pmid">29496052</pub-id></element-citation></ref><ref id="B47-antioxidants-09-00919"><label>47.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Geromanos</surname><given-names>S.J.</given-names></name><name><surname>Vissers</surname><given-names>J.P.</given-names></name><name><surname>Silva</surname><given-names>J.C.</given-names></name><name><surname>Dorschel</surname><given-names>C.A.</given-names></name><name><surname>Li</surname><given-names>G.-Z.</given-names></name><name><surname>Gorenstein</surname><given-names>M.V.</given-names></name><name><surname>Bateman</surname><given-names>R.H.</given-names></name><name><surname>Langridge</surname><given-names>J.I.</given-names></name></person-group><article-title>The detection, correlation, and comparison of peptide precursor and product ions from data independent LC-MS with data dependant LC-MS/MS</article-title><source>Proteomics</source><year>2009</year><volume>9</volume><fpage>1683</fpage><lpage>1695</lpage><pub-id pub-id-type="doi">10.1002/pmic.200800562</pub-id><?supplied-pmid 19294628?><pub-id pub-id-type="pmid">19294628</pub-id></element-citation></ref><ref id="B48-antioxidants-09-00919"><label>48.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shliaha</surname><given-names>P.V.</given-names></name><name><surname>Bond</surname><given-names>N.J.</given-names></name><name><surname>Gatto</surname><given-names>L.</given-names></name><name><surname>Lilley</surname><given-names>K.S.</given-names></name></person-group><article-title>Effects of Traveling Wave Ion Mobility Separation on Data Independent Acquisition in Proteomics Studies</article-title><source>J. Proteome Res.</source><year>2013</year><volume>12</volume><fpage>2323</fpage><lpage>2339</lpage><pub-id pub-id-type="doi">10.1021/pr300775k</pub-id><pub-id pub-id-type="pmid">23514362</pub-id></element-citation></ref><ref id="B49-antioxidants-09-00919"><label>49.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Distler</surname><given-names>U.</given-names></name><name><surname>Kuharev</surname><given-names>J.</given-names></name><name><surname>Navarro</surname><given-names>P.</given-names></name><name><surname>Levin</surname><given-names>Y.</given-names></name><name><surname>Schild</surname><given-names>H.</given-names></name><name><surname>Tenzer</surname><given-names>S.</given-names></name></person-group><article-title>Drift time-specific collision energies enable deep-coverage data-independent acquisition proteomics</article-title><source>Nat. Methods</source><year>2013</year><volume>11</volume><fpage>167</fpage><lpage>170</lpage><pub-id pub-id-type="doi">10.1038/nmeth.2767</pub-id><pub-id pub-id-type="pmid">24336358</pub-id></element-citation></ref><ref id="B50-antioxidants-09-00919"><label>50.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Perez-Riverol</surname><given-names>Y.</given-names></name><name><surname>Csordas</surname><given-names>A.</given-names></name><name><surname>Bai</surname><given-names>J.</given-names></name><name><surname>Llinares</surname><given-names>M.B.</given-names></name><name><surname>Hewapathirana</surname><given-names>S.</given-names></name><name><surname>Kundu</surname><given-names>D.J.</given-names></name><name><surname>Inuganti</surname><given-names>A.</given-names></name><name><surname>Griss</surname><given-names>J.</given-names></name><name><surname>Mayer</surname><given-names>G.</given-names></name><name><surname>Eisenacher</surname><given-names>M.</given-names></name><etal/></person-group><article-title>The PRIDE database and related tools and resources in 2019: Improving support for quantification data</article-title><source>Nucleic Acids Res.</source><year>2018</year><volume>47</volume><fpage>D442</fpage><lpage>D450</lpage><pub-id pub-id-type="doi">10.1093/nar/gky1106</pub-id></element-citation></ref><ref id="B51-antioxidants-09-00919"><label>51.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jackson</surname><given-names>L.L.</given-names></name></person-group><article-title>VTE on an elevated T-maze</article-title><source>J. Comp. Psychol.</source><year>1943</year><volume>36</volume><fpage>99</fpage><lpage>107</lpage><pub-id pub-id-type="doi">10.1037/h0058536</pub-id></element-citation></ref><ref id="B52-antioxidants-09-00919"><label>52.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sadiki</surname><given-names>F.Z.</given-names></name><name><surname>El Idrissi</surname><given-names>M.</given-names></name><name><surname>Cioanca</surname><given-names>O.</given-names></name><name><surname>Trifan</surname><given-names>A.</given-names></name><name><surname>Hancianu</surname><given-names>M.</given-names></name><name><surname>Hritcu</surname><given-names>L.</given-names></name><name><surname>Postu</surname><given-names>P.A.</given-names></name></person-group><article-title>Tetraclinis articulata essential oil mitigates cognitive deficits and brain oxidative stress in an Alzheimer&#x02019;s disease amyloidosis model</article-title><source>Phytomedicine</source><year>2018</year><volume>56</volume><fpage>57</fpage><lpage>63</lpage><pub-id pub-id-type="doi">10.1016/j.phymed.2018.10.032</pub-id><pub-id pub-id-type="pmid">30668354</pub-id></element-citation></ref><ref id="B53-antioxidants-09-00919"><label>53.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Olton</surname><given-names>D.S.</given-names></name><name><surname>Samuelson</surname><given-names>R.J.</given-names></name></person-group><article-title>Remembrance of places passed: Spatial memory in rats</article-title><source>J. Exp. Psychol. Anim. Behav. Process.</source><year>1976</year><volume>2</volume><fpage>97</fpage><lpage>116</lpage><pub-id pub-id-type="doi">10.1037/0097-7403.2.2.97</pub-id></element-citation></ref><ref id="B54-antioxidants-09-00919"><label>54.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Olton</surname><given-names>D.S.</given-names></name><name><surname>Schlosberg</surname><given-names>P.</given-names></name></person-group><article-title>Food-searching strategies in young rats: Win-shift predominates over win-stay</article-title><source>J. Comp. Physiol. Psychol.</source><year>1978</year><volume>92</volume><fpage>609</fpage><lpage>618</lpage><pub-id pub-id-type="doi">10.1037/h0077492</pub-id></element-citation></ref><ref id="B55-antioxidants-09-00919"><label>55.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Timberlake</surname><given-names>W.</given-names></name><name><surname>White</surname><given-names>W.</given-names></name></person-group><article-title>Winning isn&#x02019;t everything: Rats need only food deprivation and not food reward to efficiently traverse a radial arm maze</article-title><source>Learn. Motiv.</source><year>1990</year><volume>21</volume><fpage>153</fpage><lpage>163</lpage><pub-id pub-id-type="doi">10.1016/0023-9690(90)90017-I</pub-id></element-citation></ref><ref id="B56-antioxidants-09-00919"><label>56.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bannerman</surname><given-names>D.</given-names></name><name><surname>Sprengel</surname><given-names>R.</given-names></name><name><surname>Sanderson</surname><given-names>D.J.</given-names></name><name><surname>McHugh</surname><given-names>S.B.</given-names></name><name><surname>Rawlins</surname><given-names>J.N.P.</given-names></name><name><surname>Monyer</surname><given-names>H.</given-names></name><name><surname>Seeburg</surname><given-names>P.H.</given-names></name></person-group><article-title>Hippocampal synaptic plasticity, spatial memory and anxiety</article-title><source>Nat. Rev. Neurosci.</source><year>2014</year><volume>15</volume><fpage>181</fpage><lpage>192</lpage><pub-id pub-id-type="doi">10.1038/nrn3677</pub-id><?supplied-pmid 24552786?><pub-id pub-id-type="pmid">24552786</pub-id></element-citation></ref><ref id="B57-antioxidants-09-00919"><label>57.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Athamneh</surname><given-names>K.</given-names></name><name><surname>Alneyadi</surname><given-names>A.H.</given-names></name><name><surname>Alsamri</surname><given-names>H.</given-names></name><name><surname>Alrashedi</surname><given-names>A.</given-names></name><name><surname>Palakott</surname><given-names>A.</given-names></name><name><surname>El-Tarabily</surname><given-names>K.A.</given-names></name><name><surname>Eid</surname><given-names>A.</given-names></name><name><surname>Al-Dhaheri</surname><given-names>Y.</given-names></name><name><surname>Iratni</surname><given-names>R.</given-names></name></person-group><article-title>Origanum majorana Essential Oil Triggers p38 MAPK-Mediated Protective Autophagy, Apoptosis, and Caspase-Dependent Cleavage of P70S6K in Colorectal Cancer Cells</article-title><source>Biomolecules</source><year>2020</year><volume>10</volume><elocation-id>412</elocation-id><pub-id pub-id-type="doi">10.3390/biom10030412</pub-id><?supplied-pmid 32155920?><pub-id pub-id-type="pmid">32155920</pub-id></element-citation></ref><ref id="B58-antioxidants-09-00919"><label>58.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Amor</surname><given-names>G.</given-names></name><name><surname>Caputo</surname><given-names>L.</given-names></name><name><surname>La Storia</surname><given-names>A.</given-names></name><name><surname>De Feo</surname><given-names>V.</given-names></name><name><surname>Mauriello</surname><given-names>G.</given-names></name><name><surname>Fechtali</surname><given-names>T.</given-names></name></person-group><article-title>Chemical Composition and Antimicrobial Activity of <italic>Artemisia herba-alba</italic> and <italic>Origanum majorana</italic> Essential Oils from Morocco</article-title><source>Molecules</source><year>2019</year><volume>24</volume><elocation-id>4021</elocation-id><pub-id pub-id-type="doi">10.3390/molecules24224021</pub-id><?supplied-pmid 31698834?><pub-id pub-id-type="pmid">31698834</pub-id></element-citation></ref><ref id="B59-antioxidants-09-00919"><label>59.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nurzy&#x00144;ska-Wierdak</surname><given-names>R.</given-names></name><name><surname>Zawi&#x0015b;lak</surname><given-names>G.</given-names></name><name><surname>Kowalski</surname><given-names>R.</given-names></name></person-group><article-title>The Content and Composition of Essential Oil of <italic>Origanum majorana</italic> L. Grown in Poland Depending on Harvest Tme and Method of Raw Material Preparation</article-title><source>J. Essent. Oil Bear. Plants</source><year>2015</year><volume>18</volume><fpage>1482</fpage><lpage>1489</lpage><pub-id pub-id-type="doi">10.1080/0972060X.2013.831569</pub-id></element-citation></ref><ref id="B60-antioxidants-09-00919"><label>60.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ramos</surname><given-names>S.</given-names></name><name><surname>Rojas</surname><given-names>L.B.</given-names></name><name><surname>Lucena</surname><given-names>M.E.</given-names></name><name><surname>Meccia</surname><given-names>G.</given-names></name><name><surname>Usubillaga</surname><given-names>A.</given-names></name></person-group><article-title>Chemical Composition and Antibacterial Activity of <italic>Origanum majorana</italic> L. Essential Oil from the Venezuelan Andes</article-title><source>J. Essent. Oil Res.</source><year>2011</year><volume>23</volume><fpage>45</fpage><lpage>49</lpage><pub-id pub-id-type="doi">10.1080/10412905.2011.9700481</pub-id></element-citation></ref><ref id="B61-antioxidants-09-00919"><label>61.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maass</surname><given-names>W.</given-names></name><name><surname>Parsons</surname><given-names>J.</given-names></name><name><surname>Purao</surname><given-names>S.</given-names></name><name><surname>Storey</surname><given-names>V.C.</given-names></name><name><surname>Woo</surname><given-names>C.</given-names></name></person-group><article-title>Data-Driven Meets Theory-Driven Research in the Era of Big Data: Opportunities and Challenges for Information Systems Research</article-title><source>J. Assoc. Inf. Syst.</source><year>2018</year><volume>19</volume><fpage>1253</fpage><lpage>1273</lpage><pub-id pub-id-type="doi">10.17705/1jais.00526</pub-id></element-citation></ref><ref id="B62-antioxidants-09-00919"><label>62.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pathan</surname><given-names>M.</given-names></name><name><surname>Keerthikumar</surname><given-names>S.</given-names></name><name><surname>Ang</surname><given-names>C.-S.</given-names></name><name><surname>Gangoda</surname><given-names>L.</given-names></name><name><surname>Quek</surname><given-names>C.Y.</given-names></name><name><surname>Williamson</surname><given-names>N.A.</given-names></name><name><surname>Mouradov</surname><given-names>D.</given-names></name><name><surname>Sieber</surname><given-names>O.</given-names></name><name><surname>Simpson</surname><given-names>R.J.</given-names></name><name><surname>Salim</surname><given-names>A.</given-names></name><etal/></person-group><article-title>FunRich: An open access standalone functional enrichment and interaction network analysis tool</article-title><source>Proteomics</source><year>2015</year><volume>15</volume><fpage>2597</fpage><lpage>2601</lpage><pub-id pub-id-type="doi">10.1002/pmic.201400515</pub-id><pub-id pub-id-type="pmid">25921073</pub-id></element-citation></ref><ref id="B63-antioxidants-09-00919"><label>63.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Soliman</surname><given-names>M.M.</given-names></name><name><surname>Nassan</surname><given-names>M.A.</given-names></name><name><surname>Ismail</surname><given-names>T.A.</given-names></name></person-group><article-title><italic>Origanum Majoranum</italic> Extract Modulates Gene Expression, Hepatic and Renal Changes in a Rat Model of Type 2 Diabetes</article-title><source>Iran. J. Pharm. Res.</source><year>2016</year><volume>15</volume><fpage>45</fpage><lpage>54</lpage><pub-id pub-id-type="pmid">28228803</pub-id></element-citation></ref><ref id="B64-antioxidants-09-00919"><label>64.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>T.</given-names></name><name><surname>Zhang</surname><given-names>L.</given-names></name><name><surname>Joo</surname><given-names>D.</given-names></name><name><surname>Sun</surname><given-names>S.-C.</given-names></name></person-group><article-title>NF-&#x003ba;B signaling in inflammation</article-title><source>Signal Transduct. Target. Ther.</source><year>2017</year><volume>2</volume><fpage>17023</fpage><pub-id pub-id-type="doi">10.1038/sigtrans.2017.23</pub-id><pub-id pub-id-type="pmid">29158945</pub-id></element-citation></ref><ref id="B65-antioxidants-09-00919"><label>65.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mussbacher</surname><given-names>M.</given-names></name><name><surname>Salzmann</surname><given-names>M.</given-names></name><name><surname>Brostjan</surname><given-names>C.</given-names></name><name><surname>Hoesel</surname><given-names>B.</given-names></name><name><surname>Schoergenhofer</surname><given-names>C.</given-names></name><name><surname>Datler</surname><given-names>H.</given-names></name><name><surname>Hohensinner</surname><given-names>P.</given-names></name><name><surname>Bas&#x000ed;lio</surname><given-names>J.</given-names></name><name><surname>Petzelbauer</surname><given-names>P.</given-names></name><name><surname>Assinger</surname><given-names>A.</given-names></name><etal/></person-group><article-title>Cell Type-Specific Roles of NF-&#x003ba;B Linking Inflammation and Thrombosis</article-title><source>Front. Immunol.</source><year>2019</year><volume>10</volume><fpage>85</fpage><pub-id pub-id-type="doi">10.3389/fimmu.2019.00085</pub-id><pub-id pub-id-type="pmid">30778349</pub-id></element-citation></ref><ref id="B66-antioxidants-09-00919"><label>66.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lawrence</surname><given-names>T.</given-names></name></person-group><article-title>The Nuclear Factor NF- B Pathway in Inflammation</article-title><source>Cold Spring Harb. Perspect. Boil.</source><year>2009</year><volume>1</volume><fpage>a001651</fpage><pub-id pub-id-type="doi">10.1101/cshperspect.a001651</pub-id></element-citation></ref><ref id="B67-antioxidants-09-00919"><label>67.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lopez-Castejon</surname><given-names>G.</given-names></name><name><surname>Brough</surname><given-names>D.</given-names></name></person-group><article-title>Understanding the mechanism of IL-1&#x003b2; secretion</article-title><source>Cytokine Growth Factor Rev.</source><year>2011</year><volume>22</volume><fpage>189</fpage><lpage>195</lpage><pub-id pub-id-type="doi">10.1016/j.cytogfr.2011.10.001</pub-id><?supplied-pmid 22019906?><pub-id pub-id-type="pmid">22019906</pub-id></element-citation></ref><ref id="B68-antioxidants-09-00919"><label>68.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ramos-Payan</surname><given-names>R.</given-names></name><name><surname>Aguilar-Medina</surname><given-names>M.</given-names></name><name><surname>Estrada-Parra</surname><given-names>S.</given-names></name><name><surname>Gonz&#x000e1;lez-Y-Merchand</surname><given-names>J.A.</given-names></name><name><surname>Favila-Castillo</surname><given-names>L.</given-names></name><name><surname>Monroy-Ostria</surname><given-names>A.</given-names></name><name><surname>Estrada-Garcia</surname><given-names>I.C.E.</given-names></name></person-group><article-title>Quantification of Cytokine Gene Expression Using an Economical Real-Time Polymerase Chain Reaction Method Based on SYBRR Green I</article-title><source>Scand. J. Immunol.</source><year>2003</year><volume>57</volume><fpage>439</fpage><lpage>445</lpage><pub-id pub-id-type="doi">10.1046/j.1365-3083.2003.01250.x</pub-id><?supplied-pmid 12753500?><pub-id pub-id-type="pmid">12753500</pub-id></element-citation></ref><ref id="B69-antioxidants-09-00919"><label>69.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Allan</surname><given-names>S.M.</given-names></name><name><surname>Tyrrell</surname><given-names>P.</given-names></name><name><surname>Rothwell</surname><given-names>N.J.</given-names></name></person-group><article-title>Interleukin-1 and neuronal injury</article-title><source>Nat. Rev. Immunol.</source><year>2005</year><volume>5</volume><fpage>629</fpage><lpage>640</lpage><pub-id pub-id-type="doi">10.1038/nri1664</pub-id><?supplied-pmid 16034365?><pub-id pub-id-type="pmid">16034365</pub-id></element-citation></ref><ref id="B70-antioxidants-09-00919"><label>70.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khandelwal</surname><given-names>N.</given-names></name><name><surname>Simpson</surname><given-names>J.</given-names></name><name><surname>Taylor</surname><given-names>G.</given-names></name><name><surname>Rafique</surname><given-names>S.</given-names></name><name><surname>Whitehouse</surname><given-names>A.</given-names></name><name><surname>Hiscox</surname><given-names>J.A.</given-names></name><name><surname>Stark</surname><given-names>L.A.</given-names></name></person-group><article-title>Nucleolar NF-&#x003ba;B/RelA mediates apoptosis by causing cytoplasmic relocalization of nucleophosmin</article-title><source>Cell Death Differ.</source><year>2011</year><volume>18</volume><fpage>1889</fpage><lpage>1903</lpage><pub-id pub-id-type="doi">10.1038/cdd.2011.79</pub-id><?supplied-pmid 21660047?><pub-id pub-id-type="pmid">21660047</pub-id></element-citation></ref><ref id="B71-antioxidants-09-00919"><label>71.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Perkins</surname><given-names>N.D.</given-names></name><name><surname>Gilmore</surname><given-names>T.D.</given-names></name></person-group><article-title>Good cop, bad cop: The different faces of NF-&#x003ba;B</article-title><source>Cell Death Differ.</source><year>2006</year><volume>13</volume><fpage>759</fpage><lpage>772</lpage><pub-id pub-id-type="doi">10.1038/sj.cdd.4401838</pub-id><?supplied-pmid 16410803?><pub-id pub-id-type="pmid">16410803</pub-id></element-citation></ref><ref id="B72-antioxidants-09-00919"><label>72.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Afshin-Majd</surname><given-names>S.</given-names></name><name><surname>Khalili</surname><given-names>M.</given-names></name><name><surname>Roghani</surname><given-names>M.</given-names></name><name><surname>Mehranmehr</surname><given-names>N.</given-names></name><name><surname>Baluchnejadmojarad</surname><given-names>T.</given-names></name></person-group><article-title>Carnosine Exerts Neuroprotective Effect against 6-Hydroxydopamine Toxicity in Hemiparkinsonian Rat</article-title><source>Mol. Neurobiol.</source><year>2014</year><volume>51</volume><fpage>1064</fpage><lpage>1070</lpage><pub-id pub-id-type="doi">10.1007/s12035-014-8771-0</pub-id><pub-id pub-id-type="pmid">24939694</pub-id></element-citation></ref><ref id="B73-antioxidants-09-00919"><label>73.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morroni</surname><given-names>F.</given-names></name><name><surname>Tarozzi</surname><given-names>A.</given-names></name><name><surname>Sita</surname><given-names>G.</given-names></name><name><surname>Bolondi</surname><given-names>C.</given-names></name><name><surname>Moraga</surname><given-names>J.M.Z.</given-names></name><name><surname>Cantelli-Forti</surname><given-names>G.</given-names></name><name><surname>Hrelia</surname><given-names>P.</given-names></name></person-group><article-title>Neuroprotective effect of sulforaphane in 6-hydroxydopamine-lesioned mouse model of Parkinson&#x02019;s disease</article-title><source>NeuroToxicology</source><year>2013</year><volume>36</volume><fpage>63</fpage><lpage>71</lpage><pub-id pub-id-type="doi">10.1016/j.neuro.2013.03.004</pub-id><pub-id pub-id-type="pmid">23518299</pub-id></element-citation></ref><ref id="B74-antioxidants-09-00919"><label>74.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Strozyk</surname><given-names>E.</given-names></name><name><surname>P&#x000f6;ppelmann</surname><given-names>B.</given-names></name><name><surname>Schwarz</surname><given-names>T.</given-names></name><name><surname>Kulms</surname><given-names>D.</given-names></name></person-group><article-title>Differential effects of NF-&#x003ba;B on apoptosis induced by DNA-damaging agents: The type of DNA damage determines the final outcome</article-title><source>Oncogene</source><year>2006</year><volume>25</volume><fpage>6239</fpage><lpage>6251</lpage><pub-id pub-id-type="doi">10.1038/sj.onc.1209655</pub-id><pub-id pub-id-type="pmid">16702954</pub-id></element-citation></ref><ref id="B75-antioxidants-09-00919"><label>75.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morishima</surname><given-names>Y.</given-names></name><name><surname>Gotoh</surname><given-names>Y.</given-names></name><name><surname>Zieg</surname><given-names>J.</given-names></name><name><surname>Barrett</surname><given-names>T.</given-names></name><name><surname>Takano</surname><given-names>H.</given-names></name><name><surname>Flavell</surname><given-names>R.</given-names></name><name><surname>Davis</surname><given-names>R.J.</given-names></name><name><surname>Shirasaki</surname><given-names>Y.</given-names></name><name><surname>Greenberg</surname><given-names>M.E.</given-names></name></person-group><article-title>&#x003b2;-Amyloid Induces Neuronal Apoptosis Via a Mechanism that Involves the c-Jun N-Terminal Kinase Pathway and the Induction of Fas Ligand</article-title><source>J. Neurosci.</source><year>2001</year><volume>21</volume><fpage>7551</fpage><lpage>7560</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.21-19-07551.2001</pub-id><?supplied-pmid 11567045?><pub-id pub-id-type="pmid">11567045</pub-id></element-citation></ref><ref id="B76-antioxidants-09-00919"><label>76.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mao</surname><given-names>P.</given-names></name><name><surname>Reddy</surname><given-names>P.H.</given-names></name></person-group><article-title>Aging and amyloid beta-induced oxidative DNA damage and mitochondrial dysfunction in Alzheimer&#x02019;s disease: Implications for early intervention and therapeutics</article-title><source>Biochim. Biophys. Acta Mol. Basis Dis.</source><year>2011</year><volume>1812</volume><fpage>1359</fpage><lpage>1370</lpage><pub-id pub-id-type="doi">10.1016/j.bbadis.2011.08.005</pub-id><?supplied-pmid 21871956?><pub-id pub-id-type="pmid">21871956</pub-id></element-citation></ref><ref id="B77-antioxidants-09-00919"><label>77.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Han</surname><given-names>X.-J.</given-names></name><name><surname>Hu</surname><given-names>Y.-Y.</given-names></name><name><surname>Yang</surname><given-names>Z.-J.</given-names></name><name><surname>Jiang</surname><given-names>L.-P.</given-names></name><name><surname>Shi</surname><given-names>S.-L.</given-names></name><name><surname>Li</surname><given-names>Y.-R.</given-names></name><name><surname>Guo</surname><given-names>M.-Y.</given-names></name><name><surname>Wu</surname><given-names>H.-L.</given-names></name><name><surname>Wan</surname><given-names>Y.-Y.</given-names></name></person-group><article-title>Amyloid &#x003b2;-42 induces neuronal apoptosis by targeting mitochondria</article-title><source>Mol. Med. Rep.</source><year>2017</year><volume>16</volume><fpage>4521</fpage><lpage>4528</lpage><pub-id pub-id-type="doi">10.3892/mmr.2017.7203</pub-id><?supplied-pmid 28849115?><pub-id pub-id-type="pmid">28849115</pub-id></element-citation></ref><ref id="B78-antioxidants-09-00919"><label>78.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kechko</surname><given-names>O.I.</given-names></name><name><surname>Petrushanko</surname><given-names>I.Y.</given-names></name><name><surname>Brower</surname><given-names>C.S.</given-names></name><name><surname>Adzhubei</surname><given-names>A.A.</given-names></name><name><surname>Moskalev</surname><given-names>A.A.</given-names></name><name><surname>Piatkov</surname><given-names>K.I.</given-names></name><name><surname>Mitkevich</surname><given-names>V.A.</given-names></name><name><surname>Makarov</surname><given-names>A.A.</given-names></name></person-group><article-title>Beta-amyloid induces apoptosis of neuronal cells by inhibition of the Arg/N-end rule pathway proteolytic activity</article-title><source>Aging</source><year>2019</year><volume>11</volume><fpage>6134</fpage><lpage>6152</lpage><pub-id pub-id-type="doi">10.18632/aging.102177</pub-id><pub-id pub-id-type="pmid">31446431</pub-id></element-citation></ref><ref id="B79-antioxidants-09-00919"><label>79.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ayala</surname><given-names>A.</given-names></name><name><surname>Mu&#x000f1;oz</surname><given-names>M.F.</given-names></name><name><surname>Arguelles</surname><given-names>S.</given-names></name></person-group><article-title>Lipid Peroxidation: Production, Metabolism, and Signaling Mechanisms of Malondialdehyde and 4-Hydroxy-2-Nonenal</article-title><source>Oxidative Med. Cell. Longev.</source><year>2014</year><volume>2014</volume><fpage>360438</fpage><pub-id pub-id-type="doi">10.1155/2014/360438</pub-id></element-citation></ref><ref id="B80-antioxidants-09-00919"><label>80.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Curtis</surname><given-names>J.M.</given-names></name><name><surname>Hahn</surname><given-names>W.S.</given-names></name><name><surname>Long</surname><given-names>E.K.</given-names></name><name><surname>Burrill</surname><given-names>J.S.</given-names></name><name><surname>Arriaga</surname><given-names>E.A.</given-names></name><name><surname>Bernlohr</surname><given-names>D.A.</given-names></name></person-group><article-title>Protein carbonylation and metabolic control systems</article-title><source>Trends Endocrinol. Metab.</source><year>2012</year><volume>23</volume><fpage>399</fpage><lpage>406</lpage><pub-id pub-id-type="doi">10.1016/j.tem.2012.05.008</pub-id><pub-id pub-id-type="pmid">22742812</pub-id></element-citation></ref><ref id="B81-antioxidants-09-00919"><label>81.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dalle-Donne</surname><given-names>I.</given-names></name><name><surname>Aldini</surname><given-names>G.</given-names></name><name><surname>Carini</surname><given-names>M.</given-names></name><name><surname>Colombo</surname><given-names>R.</given-names></name><name><surname>Rossi</surname><given-names>R.</given-names></name><name><surname>Milzani</surname><given-names>A.D.G.</given-names></name></person-group><article-title>Protein carbonylation, cellular dysfunction, and disease progression</article-title><source>J. Cell. Mol. Med.</source><year>2007</year><volume>10</volume><fpage>389</fpage><lpage>406</lpage><pub-id pub-id-type="doi">10.1111/j.1582-4934.2006.tb00407.x</pub-id></element-citation></ref><ref id="B82-antioxidants-09-00919"><label>82.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zuo</surname><given-names>L.</given-names></name><name><surname>Hemmelgarn</surname><given-names>B.T.</given-names></name><name><surname>Chuang</surname><given-names>C.-C.</given-names></name><name><surname>Best</surname><given-names>T.M.</given-names></name></person-group><article-title>The Role of Oxidative Stress-Induced Epigenetic Alterations in Amyloid-&#x003b2; Production in Alzheimer&#x02019;s Disease</article-title><source>Oxidative Med. Cell. Longev.</source><year>2015</year><volume>2015</volume><fpage>604658</fpage><pub-id pub-id-type="doi">10.1155/2015/604658</pub-id></element-citation></ref><ref id="B83-antioxidants-09-00919"><label>83.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Butterfield</surname><given-names>D.A.</given-names></name><name><surname>Swomley</surname><given-names>A.M.</given-names></name><name><surname>Sultana</surname><given-names>R.</given-names></name></person-group><article-title>Amyloid &#x003b2;-Peptide (1&#x02013;42)-Induced Oxidative Stress in Alzheimer Disease: Importance in Disease Pathogenesis and Progression</article-title><source>Antioxid. Redox Signal.</source><year>2013</year><volume>19</volume><fpage>823</fpage><lpage>835</lpage><pub-id pub-id-type="doi">10.1089/ars.2012.5027</pub-id><pub-id pub-id-type="pmid">23249141</pub-id></element-citation></ref><ref id="B84-antioxidants-09-00919"><label>84.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Deuschle</surname><given-names>R.A.N.</given-names></name><name><surname>Deuschle</surname><given-names>V.C.K.N.</given-names></name><name><surname>Bonfanti-Azzolin</surname><given-names>G.</given-names></name><name><surname>De Oliveira</surname><given-names>J.S.</given-names></name><name><surname>Sostisso</surname><given-names>Q.C.B.</given-names></name><name><surname>Goulart</surname><given-names>J.D.S.</given-names></name><name><surname>Mayer</surname><given-names>M.S.</given-names></name><name><surname>Horn</surname><given-names>R.C.</given-names></name><name><surname>Golle</surname><given-names>D.P.</given-names></name></person-group><article-title>Phytochemical Screening and Antioxidant Activity of Origanum majorana against Oxidative Stress Biomarkers</article-title><source>J. Agric. Sci.</source><year>2018</year><volume>10</volume><fpage>395</fpage><pub-id pub-id-type="doi">10.5539/jas.v10n12p395</pub-id></element-citation></ref><ref id="B85-antioxidants-09-00919"><label>85.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Soliman</surname><given-names>A.M.</given-names></name><name><surname>Desouky</surname><given-names>S.</given-names></name><name><surname>Marzouk</surname><given-names>M.</given-names></name><name><surname>Sayed</surname><given-names>A.A.</given-names></name></person-group><article-title>Origanum majorana Attenuates Nephrotoxicity of Cisplatin Anticancer Drug through Ameliorating Oxidative Stress</article-title><source>Nutrients</source><year>2016</year><volume>8</volume><elocation-id>264</elocation-id><pub-id pub-id-type="doi">10.3390/nu8050264</pub-id><?supplied-pmid 27164131?><pub-id pub-id-type="pmid">27164131</pub-id></element-citation></ref><ref id="B86-antioxidants-09-00919"><label>86.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moghaddam</surname><given-names>M.G.</given-names></name><name><surname>Ansari</surname><given-names>I.</given-names></name><name><surname>Roghani</surname><given-names>M.</given-names></name><name><surname>Moradi</surname><given-names>M.</given-names></name></person-group><article-title>The Effects of <italic>Origanum Majorana</italic> on Oxidative Stress and Histopathology of Renal Tissue among Streptozotocin-Induced Diabetic Rats</article-title><source>Thrita J. Med. Sci.</source><year>2013</year><volume>2</volume><fpage>29</fpage><lpage>34</lpage><pub-id pub-id-type="doi">10.5812/thrita.9282</pub-id></element-citation></ref><ref id="B87-antioxidants-09-00919"><label>87.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kowia&#x00144;ski</surname><given-names>P.</given-names></name><name><surname>Lietzau</surname><given-names>G.</given-names></name><name><surname>Czuba</surname><given-names>E.</given-names></name><name><surname>Wa&#x0015b;kow</surname><given-names>M.</given-names></name><name><surname>Steliga</surname><given-names>A.</given-names></name><name><surname>Morys</surname><given-names>J.</given-names></name></person-group><article-title>BDNF: A Key Factor with Multipotent Impact on Brain Signaling and Synaptic Plasticity</article-title><source>Cell. Mol. Neurobiol.</source><year>2017</year><volume>38</volume><fpage>579</fpage><lpage>593</lpage><pub-id pub-id-type="doi">10.1007/s10571-017-0510-4</pub-id><?supplied-pmid 28623429?><pub-id pub-id-type="pmid">28623429</pub-id></element-citation></ref><ref id="B88-antioxidants-09-00919"><label>88.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cohen-Cory</surname><given-names>S.</given-names></name><name><surname>Kidane</surname><given-names>A.H.</given-names></name><name><surname>Shirkey</surname><given-names>N.J.</given-names></name><name><surname>Marshak</surname><given-names>S.</given-names></name></person-group><article-title>Brain-derived neurotrophic factor and the development of structural neuronal connectivity</article-title><source>Dev. Neurobiol.</source><year>2010</year><volume>70</volume><fpage>271</fpage><lpage>288</lpage><pub-id pub-id-type="doi">10.1002/dneu.20774</pub-id><?supplied-pmid 20186709?><pub-id pub-id-type="pmid">20186709</pub-id></element-citation></ref><ref id="B89-antioxidants-09-00919"><label>89.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>L.</given-names></name><name><surname>Fang</surname><given-names>Y.</given-names></name><name><surname>Lian</surname><given-names>Y.</given-names></name><name><surname>Chen</surname><given-names>Y.</given-names></name><name><surname>Wu</surname><given-names>T.</given-names></name><name><surname>Zheng</surname><given-names>Y.</given-names></name><name><surname>Zong</surname><given-names>H.</given-names></name><name><surname>Sun</surname><given-names>L.</given-names></name><name><surname>Zhang</surname><given-names>R.</given-names></name><name><surname>Wang</surname><given-names>Z.</given-names></name><etal/></person-group><article-title>Brain-Derived Neurotrophic Factor Ameliorates Learning Deficits in a Rat Model of Alzheimer&#x02019;s Disease Induced by A&#x003b2;1-42</article-title><source>PLoS ONE</source><year>2015</year><volume>10</volume><elocation-id>e0122415</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0122415</pub-id><pub-id pub-id-type="pmid">25849905</pub-id></element-citation></ref><ref id="B90-antioxidants-09-00919"><label>90.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>L.</given-names></name><name><surname>Fang</surname><given-names>Y.</given-names></name><name><surname>Xu</surname><given-names>Y.</given-names></name><name><surname>Lian</surname><given-names>Y.</given-names></name><name><surname>Xie</surname><given-names>N.</given-names></name><name><surname>Wu</surname><given-names>T.</given-names></name><name><surname>Zhang</surname><given-names>H.</given-names></name><name><surname>Sun</surname><given-names>L.</given-names></name><name><surname>Zhang</surname><given-names>R.</given-names></name><name><surname>Wang</surname><given-names>Z.</given-names></name></person-group><article-title>Curcumin Improves Amyloid &#x003b2;-Peptide (1-42) Induced Spatial Memory Deficits through BDNF-ERK Signaling Pathway</article-title><source>PLoS ONE</source><year>2015</year><volume>10</volume><elocation-id>e0131525</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0131525</pub-id><pub-id pub-id-type="pmid">26114940</pub-id></element-citation></ref><ref id="B91-antioxidants-09-00919"><label>91.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>G&#x000fc;rb&#x000fc;z</surname><given-names>P.</given-names></name><name><surname>Martinez</surname><given-names>A.</given-names></name><name><surname>P&#x000e9;rez</surname><given-names>C.</given-names></name><name><surname>Mart&#x000ed;nez-Gonz&#x000e1;lez</surname><given-names>L.</given-names></name><name><surname>G&#x000f6;ger</surname><given-names>F.</given-names></name><name><surname>Ayran</surname><given-names>I.</given-names></name></person-group><article-title>Potential anti-Alzheimer effects of selected Lamiaceae plants through polypharmacology on glycogen synthase kinase-3&#x003b2;, &#x003b2;-secretase, and casein kinase 1&#x003b4;</article-title><source>Ind. Crop. Prod.</source><year>2019</year><volume>138</volume><fpage>111431</fpage><pub-id pub-id-type="doi">10.1016/j.indcrop.2019.05.080</pub-id></element-citation></ref></ref-list></back><floats-group><fig id="antioxidants-09-00919-f001" orientation="portrait" position="float"><label>Figure 1</label><caption><p>The experimental design of drug treatment and behavioral measurements.</p></caption><graphic xlink:href="antioxidants-09-00919-g001"/></fig><fig id="antioxidants-09-00919-f002" orientation="portrait" position="float"><label>Figure 2</label><caption><p>Abundance comparison of 1224 identified proteins in rat brain tissues. Ordering by abundance in A&#x003b2;1-42 (II; red dots). Protein abundances from A&#x003b2;1-42 and 1%OmEO (III; light green squares) and A&#x003b2;1-42 and 3%OmEO (IV; dark green diamonds) are overlaid. With numbers (red: above and black: below) are marked the proteins whose abundances were modulated by OmEO. The 2&#x000d7; threshold is represented by dark grey line and the 3&#x000d7; threshold by the light grey line. The blue vertical dashed lines mark borders in between which differential abundances were analyzed.</p></caption><graphic xlink:href="antioxidants-09-00919-g002"/></fig><fig id="antioxidants-09-00919-f003" orientation="portrait" position="float"><label>Figure 3</label><caption><p>Effects of the inhaled <italic>Origanum majorana</italic> essential oil (1%OmEO (III) and 3%OmEO (IV)) on the IL-1&#x003b2; mRNA copy number estimated in the rat hippocampal homogenates of the A&#x003b2;1-42-treated rats. Values are means &#x000b1; S.E.M. (<italic>n</italic> = 3 animals per group). Statistical significance was determined by one-way ANOVA. For Tukey&#x02019;s <italic>post hoc</italic> analyses: Sham (I) vs. A&#x003b2;1-42 (II): ** <italic>p</italic> = 0.0032.</p></caption><graphic xlink:href="antioxidants-09-00919-g003"/></fig><fig id="antioxidants-09-00919-f004" orientation="portrait" position="float"><label>Figure 4</label><caption><p>Effects of the inhaled <italic>Origanum majorana</italic> essential oil (1%OmEO (III) and 3%OmEO (IV)) on apoptotic state in the rat hippocampal homogenates of the A&#x003b2;1-42-treated rats. Values are means &#x000b1; S.E.M. (<italic>n</italic> = 3 animals per group). Statistical significance was determined by one-way ANOVA. For Tukey&#x02019;s post hoc analyses: Sham (I) vs. A&#x003b2;1-42 (II): *** <italic>p</italic> = 0.0008. The rate of apoptosis reflects n-fold nucleosomes enrichment and it is shown on the Y axis.</p></caption><graphic xlink:href="antioxidants-09-00919-g004"/></fig><fig id="antioxidants-09-00919-f005" orientation="portrait" position="float"><label>Figure 5</label><caption><p>Effects of the inhaled <italic>Origanum majorana</italic> essential oil (1%OmEO (III) and 3%OmEO (IV)) on the MDA (<bold>A</bold>) and protein carbonyls (<bold>B</bold>) levels estimated in the rat hippocampal homogenates of the A&#x003b2;1-42-treated rats. Values are means &#x000b1; S.E.M. (<italic>n</italic> = 3 animals per group). Statistical significance was determined by one-way ANOVA. For Tukey&#x02019;s <italic>post hoc</italic> analyses: A. Sham (I) vs. A&#x003b2;1-42 (II): * <italic>p</italic> = 0.0110, A&#x003b2;1-42 (II) vs. A&#x003b2;1-42 + 1%OmEO (III): ## <italic>p</italic> = 0.0023 and A&#x003b2;1-42 (II) vs. A&#x003b2;1-42 + 3%OmEO (IV): # <italic>p</italic> = 0.0015; B. Sham (I) vs. A&#x003b2;1-42 (II): * <italic>p</italic> = 0.0283 and A&#x003b2;1-42 (II) vs. A&#x003b2;1-42 + 1%OmEO (III): # <italic>p</italic> = 0.0224.</p></caption><graphic xlink:href="antioxidants-09-00919-g005"/></fig><fig id="antioxidants-09-00919-f006" orientation="portrait" position="float"><label>Figure 6</label><caption><p>Effects of the inhaled <italic>Origanum majorana</italic> essential oil (1%OmEO (III) and 3%OmEO (IV)) on the BDNF mRNA copy number estimated in the rat hippocampal homogenates of the A&#x003b2;1-42-treated rats. Values are means &#x000b1; S.E.M. (<italic>n</italic> = 3 animals per group). Statistical significance was determined by one-way ANOVA. For Tukey&#x02019;s <italic>post hoc</italic> analyses: Sham (I) vs. A&#x003b2;1-42 (II): **** <italic>p</italic> &#x0003c; 0.0001 and A&#x003b2;1-42 (II) vs. A&#x003b2;1-42 + 1%OmEO (III): ## <italic>p</italic> = 0.0023.</p></caption><graphic xlink:href="antioxidants-09-00919-g006"/></fig><fig id="antioxidants-09-00919-f007" orientation="portrait" position="float"><label>Figure 7</label><caption><p>Effects of the inhaled <italic>Origanum majorana</italic> essential oil (1%OmEO (III) and 3%OmEO (IV)) on the spontaneous alternation percentage (<bold>A</bold>) and locomotor activity (<bold>B</bold>) in the Y-maze test and on the working memory errors (<bold>C</bold>) and reference memory errors (<bold>D</bold>) during seven-day training in the radial arm-maze test in the A&#x003b2;1-42-treated rats. Values are means &#x000b1; S.E.M. (<italic>n</italic> = 7 animals per group). Statistical significance was determined by one-way ANOVA. For Tukey&#x02019;s <italic>post hoc</italic> analyses: A. Sham (I) vs. A&#x003b2;1-42 (II): ** <italic>p</italic> = 0.0048 and A&#x003b2;1-42 (II) vs. A&#x003b2;1-42 + 1%OmEO (III): ## <italic>p</italic> = 0.0018; C. Sham (I) vs. A&#x003b2;1-42 (II): **** <italic>p</italic> &#x0003c; 0.0001; A&#x003b2;1-42 (II) vs. A&#x003b2;1-42 + 1%OmEO (III): #### <italic>p</italic> &#x0003c; 0.0001 and A&#x003b2;1-42 (II) vs. A&#x003b2;1-42 + 3%OmEO (IV): #### <italic>p</italic> &#x0003c; 0.0001; D. Sham (I) vs. A&#x003b2;1-42 (II): **** <italic>p</italic> &#x0003c; 0.0001 and A&#x003b2;1-42 (II) vs. A&#x003b2;1-42 + 1%OmEO (III): # <italic>p</italic> = 0.0142.</p></caption><graphic xlink:href="antioxidants-09-00919-g007"/></fig><table-wrap id="antioxidants-09-00919-t001" orientation="portrait" position="float"><object-id pub-id-type="pii">antioxidants-09-00919-t001_Table 1</object-id><label>Table 1</label><caption><p>List of proteins whose expression in brain was suspected to be modulated by OmEO, gene ontology grouping, and functional assay assignment.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Rank <sup>(a)</sup></th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">No. <sup>(b)</sup></th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Protein Name <sup>(b)</sup></th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Cellular Component/Molecular Function/Biological Process <sup>(c)</sup></th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Assay <sup>(d)</sup></th></tr></thead><tbody><tr><td align="center" valign="middle" rowspan="1" colspan="1">320</td><td align="center" valign="middle" rowspan="1" colspan="1">P30009</td><td align="center" valign="middle" rowspan="1" colspan="1">Myristoylated alanine-rich C-kinase substrate</td><td align="center" valign="middle" rowspan="1" colspan="1">postsynaptic cytoskeleton/calmodulin binding/positive regulation of neuron projection development</td><td align="center" valign="middle" rowspan="1" colspan="1">cognitive function</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">487</td><td align="center" valign="middle" rowspan="1" colspan="1">Q08163</td><td align="center" valign="middle" rowspan="1" colspan="1">Adenylyl cyclase-associated protein 1</td><td align="center" valign="middle" rowspan="1" colspan="1">cortical actin cytoskeleton/actin binding/actin cytoskeleton organization</td><td align="center" valign="middle" rowspan="1" colspan="1">n.a.</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">602</td><td align="center" valign="middle" rowspan="1" colspan="1">M0RBL8</td><td align="center" valign="middle" rowspan="1" colspan="1">Transcription elongation factor A (SII)-like 6</td><td align="center" valign="middle" rowspan="1" colspan="1">nucleus/WW domain binding/n.d.</td><td align="center" valign="middle" rowspan="1" colspan="1">n.a.</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">620</td><td align="center" valign="middle" rowspan="1" colspan="1">P31232</td><td align="center" valign="middle" rowspan="1" colspan="1">Transgelin</td><td align="center" valign="middle" rowspan="1" colspan="1">cytoplasm/actin filament binding/epithelial cell differentiation</td><td align="center" valign="middle" rowspan="1" colspan="1">n.a.</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">657</td><td align="center" valign="middle" rowspan="1" colspan="1">Q9EPH2</td><td align="center" valign="middle" rowspan="1" colspan="1">MARCKS-related protein</td><td align="center" valign="middle" rowspan="1" colspan="1">anchored component of presynaptic membrane/calmodulin binding/positive regulation of cell population proliferation</td><td align="center" valign="middle" rowspan="1" colspan="1">cognitive function</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">761</td><td align="center" valign="middle" rowspan="1" colspan="1">P84083</td><td align="center" valign="middle" rowspan="1" colspan="1">ADP-ribosylation factor 5</td><td align="center" valign="middle" rowspan="1" colspan="1">perinuclear region of cytoplasm/GTP binding/vesicle-mediated transport</td><td align="center" valign="middle" rowspan="1" colspan="1">n.a.</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">782</td><td align="center" valign="middle" rowspan="1" colspan="1">P60901</td><td align="center" valign="middle" rowspan="1" colspan="1">Proteasome subunit alpha type-6</td><td align="center" valign="middle" rowspan="1" colspan="1">cytoplasm/threonine-type endopeptidase activity/positive regulation of NF-&#x003ba;B transcription factor activity</td><td align="center" valign="middle" rowspan="1" colspan="1">apoptosis a/o neuroinflammation</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">896</td><td align="center" valign="middle" rowspan="1" colspan="1">Q6AY41</td><td align="center" valign="middle" rowspan="1" colspan="1">Cell cycle control protein 50A</td><td align="center" valign="middle" rowspan="1" colspan="1">Golgi apparatus and membrane/aminophospholipid flippase activity/positive regulation of neuron projection development</td><td align="center" valign="middle" rowspan="1" colspan="1">cognitive function</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">899</td><td align="center" valign="middle" rowspan="1" colspan="1">P34067</td><td align="center" valign="middle" rowspan="1" colspan="1">Proteasome subunit beta type-4</td><td align="center" valign="middle" rowspan="1" colspan="1">cytoplasm/threonine-type endopeptidase activity/proteasome-mediated ubiquitin-dependent protein catabolic process</td><td align="center" valign="middle" rowspan="1" colspan="1">oxidative stress</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">1012</td><td align="center" valign="middle" rowspan="1" colspan="1">Q6AXS5</td><td align="center" valign="middle" rowspan="1" colspan="1">Plasminogen activator inhibitor 1 RNA-binding protein</td><td align="center" valign="middle" rowspan="1" colspan="1">cytoplasm/mRNA 3&#x02032;-UTR binding/regulation of apoptotic process</td><td align="center" valign="middle" rowspan="1" colspan="1">apoptosis</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">1021</td><td align="center" valign="middle" rowspan="1" colspan="1">P06302</td><td align="center" valign="middle" rowspan="1" colspan="1">Prothymosin alpha</td><td align="center" valign="middle" rowspan="1" colspan="1">nucleus/NF-&#x003ba;B binding/positive regulation of NF-&#x003ba;B transcription factor activity and negative regulation of apoptotic process</td><td align="center" valign="middle" rowspan="1" colspan="1">apoptosis a/o neuroinflammation</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">1118</td><td align="center" valign="middle" rowspan="1" colspan="1">Q5M821</td><td align="center" valign="middle" rowspan="1" colspan="1">Protein phosphatase 1H</td><td align="center" valign="middle" rowspan="1" colspan="1">n.d./protein serine/threonine phosphatase activity/positive regulation of pyruvate dehydrogenase activity</td><td align="center" valign="middle" rowspan="1" colspan="1">n.a.</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">1119</td><td align="center" valign="middle" rowspan="1" colspan="1">P01835</td><td align="center" valign="middle" rowspan="1" colspan="1">Ig kappa chain C region, B allele</td><td align="center" valign="middle" rowspan="1" colspan="1">n.d./n.d./n.d.</td><td align="center" valign="middle" rowspan="1" colspan="1">n.a.</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">1146</td><td align="center" valign="middle" rowspan="1" colspan="1">Q63941</td><td align="center" valign="middle" rowspan="1" colspan="1">Ras-related protein Rab-3</td><td align="center" valign="middle" rowspan="1" colspan="1">endomembrane system/GTP binding/peptidyl-cysteine methylation</td><td align="center" valign="middle" rowspan="1" colspan="1">oxidative stress</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">1150</td><td align="center" valign="middle" rowspan="1" colspan="1">P13084</td><td align="center" valign="middle" rowspan="1" colspan="1">Nucleophosmin</td><td align="center" valign="middle" rowspan="1" colspan="1">ribonucleoprotein complex/identical protein binding/positive regulation of NF-&#x003ba;B transcription factor activity</td><td align="center" valign="middle" rowspan="1" colspan="1">apoptosis a/o neuroinflammation</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">1159</td><td align="center" valign="middle" rowspan="1" colspan="1">Q5XIU9</td><td align="center" valign="middle" rowspan="1" colspan="1">Membrane-associated progesterone receptor component 2</td><td align="center" valign="middle" rowspan="1" colspan="1">membrane/steroid binding/adipose tissue development</td><td align="center" valign="middle" rowspan="1" colspan="1">n.a.</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1160</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">P25093</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Fumarylacetoacetase</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">n.d./metal ion binding/homogentisate catabolic process</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">oxidative stress</td></tr></tbody></table><table-wrap-foot><fn><p><sup>(a)</sup> see <xref ref-type="fig" rid="antioxidants-09-00919-f002">Figure 2</xref>; <sup>(b)</sup> UniProt data base entry; <sup>(c)</sup> determined by Funrich [<xref rid="B62-antioxidants-09-00919" ref-type="bibr">62</xref>]; n.d.: not determined; <sup>(d)</sup> investigated by standard biochemical and/or molecular biology assay; n.a.: not assayed.</p></fn></table-wrap-foot></table-wrap></floats-group></article>